Back To Index  <<  Back To Terminology

ref Value Set ELGA_whoATC 2013‑01‑10

Id 1.2.40.0.34.10.73 Gültigkeit gültig ab 2013‑01‑10
Status final Definitiv Versions-Label
Name ELGA_whoATC Anzeigename ELGA_whoATC
Beschreibung ELGA Valueset für ATC
Quell-Codesystem
2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification
Level/ Typ Code Anzeigename Codesystem
0‑L
A
Alimentäres System und Stoffwechsel
WHO Anatomical Therapeutic Chemical classification
0‑L
A01
Stomatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
A01a
Stomatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA
Mittel zur Kariesprophylaxe
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA01
Natriumfluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA02
Natriummonofluorphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA03
Olaflur
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA04
Zinn(II)-fluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA51
Natriumfluorid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB
Antiinfektiva und Antiseptika zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB02
Wasserstoffperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB03
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB04
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB05
Polynoxylin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB06
Domiphen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB07
Oxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB08
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB09
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB10
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB11
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB12
Hexetidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB13
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB14
Benzoxoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB15
Tibezoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB16
Mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB17
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB18
Clotrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB19
Natriumperborat
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB21
Chlortetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB22
Doxycyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB23
Minocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC
Corticosteroide zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC01
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC02
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC03
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC54
Prednisolon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD
Andere Mittel zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD01
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD02
Benzydamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD05
Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD06
Adrenalon
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD07
Amlexanox
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD11
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
A02
Mittel bei säure bedingten Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02A
Antacida
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA
Magnesium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA01
Magnesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA02
Magnesiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA03
Magnesiumperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA04
Magnesiumhydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA05
Magnesiumsilikat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB
Aluminium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB01
Aluminiumhydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB02
Algeldrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB03
Aluminiumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB04
Dihydroxyalumiumnatriumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB05
Aluminiumacetoacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB06
Aloglutamol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB07
Aluminiumglycinat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC
Calcium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC01
Calciumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC02
Calciumsilikat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD
Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD01
Einfache Salzkombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD02
Magaldrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD03
Almagat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD04
Hydrotalcit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD05
Almasilat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF
Antacida mit Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF01
Magaldrat und Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF02
Einfache Salzkombinationen und Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AG
Antacida mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AH
Antacida mit Natriumbicarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AX
Antacida, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02B
Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA
Histamin-H2-Rezeptorantagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA01
Cimetidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA02
Ranitidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA03
Famotidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA04
Nizatidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA05
Niperotidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA06
Roxatidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA07
Ranitidinbismutcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA08
Lafutidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA51
Cimetidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA53
Famotidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB
Prostaglandine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB01
Misoprostol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB02
Enprostil
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC
Protonenpumpenhemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC01
Omeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC02
Pantoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC03
Lansoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC04
Rabeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC05
Esomeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC06
Dexlansoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD
Kombinationen zur Eradikation von Helicobacter pylori
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD01
Omeprazol, Amoxicillin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD02
Lansoprazol, Tetracyclin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD03
Lansoprazol, Amoxicillin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD04
Pantoprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD05
Omeprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD06
Esomeprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD08
Bismutsubcitrat, Tetracyclin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX
Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX01
Carbenoxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX02
Sucralfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX03
Pirenzepin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX04
Methiosulfoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX05
Bismutsubcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX06
Proglumid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX07
Gefarnat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX08
Sulglicotid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX09
Acetoxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX10
Zolimidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX11
Troxipid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX12
Bismutsubnitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX13
Alginsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX51
Carbenoxolon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX71
Carbenoxolon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX77
Gefarnat, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02X
Andere Mittel bei säure bedingten Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03
Mittel bei funktionellen gastrointestinalen Störungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03A
Mittel bei funktionellen Störungen des Darms
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA
Synthetische Anticholinergika, Ester mit tertiären Aminogruppen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA01
Oxyphencyclimin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA03
Camylofin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA04
Mebeverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA05
Trimebutin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA06
Rociverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA07
Dicycloverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA08
Dihexyverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA09
Difemerin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA30
Piperidolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB
Synthetische Anticholinergika, quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB01
Benzilon
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB02
Glycopyrronium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB03
Oxyphenonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB04
Penthienat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB05
Propanthelin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB06
Otiloniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB07
Methanthelinium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB08
Tridihexethyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB09
Isopropamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB10
Hexocyclium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB11
Poldin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB12
Mepenzolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB13
Bevonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB14
Pipenzolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB15
Diphemanil
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB16
(2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB17
Tiemoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB18
Prifiniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB19
Timepidiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB21
Fenpiverinium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB53
Oxyphenonium, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC
Synthetische Spasmolytika, Amide mit tertiären Aminen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC02
Dimethylaminopropionylphenothiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC04
Nicofetamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC05
Tiropramid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD
Papaverin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD01
Papaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD02
Drotaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD30
Moxaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE
Auf Serotonin-Rezeptoren wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE01
Alosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE02
Tegaserod
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE03
Cilansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX
Andere Mittel bei funktionellen Störungen des Darms
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX01
Fenpipran
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX02
Diisopromin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX03
Chlorbenzoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX04
Pinaverium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX05
Fenoverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX06
Idanpramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX07
Proxazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX08
Alverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX09
Trepibuton
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX10
Isomethepten
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX11
Caroverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX12
Phloroglucinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX13
Silikone
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX30
Trimethyldiphenylpropylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX58
Alverin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03B
BELLADONNA UND DERIVATE, REIN
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA
Belladonna-Alkaloide, tertiäre Amine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA01
Atropin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA03
Hyoscyamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA04
Belladonna-Gesamtalkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB
Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB01
Butylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB02
Methylatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB03
Methylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB04
Fentonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB05
Cimetropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03C
Spasmolytika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA
Synthetische Anticholinergika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA01
Isopropamid und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA02
Clidinium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA03
Oxyphencyclimin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA04
Otiloniumbromid und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA05
Glycopyrronium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA06
Bevonium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA07
Ambutonium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA08
Diphemanil und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA30
Emepronium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA34
Propanthelin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB
Belladonna und Derivate in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB01
Methylscopolamin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB02
Belladonna-Gesamtalkaloide und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB03
Atropin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB04
Methylhomatropin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB31
Hyoscyamin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CC
Andere Spasmolytika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03D
Spasmolytika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA
Synthetische Anticholinergika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA01
Tropenzilon und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA02
Pitofenon und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA03
Bevonium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA04
Ciclonium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA05
Camylofin und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA06
Trospium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA07
Tiemoniumiodid und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB
Belladonna und Derivate in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB04
Butylscopolamin und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DC
Andere Spasmolytika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03E
Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
A03EA
Spasmolytika, Psycholeptika und Analgetika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A03ED
Spasmolytika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
A03F
Prokinetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA
Prokinetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA01
Metoclopramid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA02
Cisaprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA03
Domperidon
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA04
Bromoprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA05
Alizaprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA06
Cleboprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A04
Antiemetika und Mittel gegen Übelkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
A04A
Antiemetika und Mittel gegen Übelkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA
Serotonin-5HT3-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA01
Ondansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA02
Granisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA03
Tropisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA04
Dolasetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA05
Palonosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD
Andere Antiemetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD01
Scopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD02
Ceriumoxalat
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD04
Chlorbutanol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD05
Metopimazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD10
Dronabinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD11
Nabilon
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD12
Aprepitant
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD51
Scopolamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD54
Chlorbutanol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05
Gallen- und Lebertherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05A
Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA
Gallensäure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA01
Chenodeoxycholsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA02
Ursodeoxycholsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB
Zubereitungen zur Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB01
N-(Hydroxymethyl)nicotinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX
Andere Mittel zur Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX01
Piprozolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX02
Hymecromon
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX03
Cyclobutyrol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05B
Lebertherapie, Lipotrope Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA
Lebertherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA01
Argininglutamat
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA03
Silymarin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA04
Citiolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA05
Epomediol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA06
Ornithinoxoglurat
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA07
Tidiacicarginin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05C
Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06
Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06A
Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA
Gleitmittel, Emollientia
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA01
Dickflüssiges Paraffin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA02
Docusat-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA51
Dickflüssiges Paraffin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB
Kontaktlaxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB01
Oxyphenisatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB02
Bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB03
Dantron
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB04
Phenolphthalein
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB05
Rizinusöl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB06
Sennoside
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB07
Cascara
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB08
Natriumpicosulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB09
Bisoxatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB20
Kontaktlaxanzien in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB30
Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB52
Bisacodyl, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB53
Dantron, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB56
Sennoside, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB57
Cascara, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB58
Natriumpicosulfat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC
Quellmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC01
Ispaghula (Flohsamen)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC02
Ethulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC03
Sterculia
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC05
Leinsamen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC06
Methylcellulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC07
Triticum (Weizenkleie)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC08
Polycarbophil-Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC51
Ispaghula, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC53
Sterculia, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC55
Leinsamen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD
Osmotisch wirkende Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD01
Magnesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD02
Magnesiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD03
Magnesiumperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD04
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD10
Mineralsalze in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD11
Lactulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD12
Lactitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD13
Natriumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD14
Pentaerythrityl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD15
Macrogol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD16
Mannitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD17
Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD18
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD19
Magnesiumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD21
Natriumtartrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD61
Lactulose, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD65
Macrogol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG
Klysmen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG01
Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG02
Bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG03
Dantron, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG04
Glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG06
Öl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG07
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG10
Docusat-Natrium, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG11
Laurylsulfat, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AH01
Methylnaltrexon bromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX
Andere Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX01
Glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX02
Kohlendioxid-freisetzende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A07
Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07A
Intestinale Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA01
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA02
Nystatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA03
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA04
Streptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA05
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA06
Paromomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA07
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA08
Kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA09
Vancomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA10
Colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA11
Rifaximin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA12
Fidaxomicin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA51
Neomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA54
Streptomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB
Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB02
Phthalylsulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB03
Sulfaguanidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB04
Succinylsulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC
Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC01
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX
Andere intestinale Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX01
Broxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX02
Acetarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX03
Nifuroxazid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX04
Nifurzid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07B
Intestinale Adsorbenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA
Kohle-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA01
Medizinische Kohle
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA51
Medizinische Kohle, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BB
Bismut-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC
Andere intestinale Adsorbenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC01
Pektin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC02
Kaolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC03
Crospovidon
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC04
Attapulgit
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC05
Diosmectit
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC54
Attapulgit, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07C
Elektrolyte mit Kohlenhydraten
WHO Anatomical Therapeutic Chemical classification
0‑L
A07CA
Elektrolyte zur oralen Rehydrierung
WHO Anatomical Therapeutic Chemical classification
0‑L
A07D
Motilitätshemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA
Motilitätshemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA01
Diphenoxylat
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA02
Opium
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA03
Loperamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA04
Difenoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA05
Loperamidoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA52
Morphin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA53
Loperamid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07E
Intestinale Antiphlogistika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA
Corticosteroide mit lokaler Wirkung
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA01
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA02
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA03
Prednison
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA04
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA05
Tixocortol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA06
Budesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA07
Beclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB
Antiallergika, exkl. Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB01
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC
Aminosalicylsäure und ähnliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC01
Sulfasalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC02
Mesalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC03
Olsalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC04
Balsalazid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07F
Mikrobielle Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA
Mikrobielle Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA01
Milchsäurebildner
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA02
Saccharomyces boulardii
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA51
Milchsäurebildner, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07X
Andere Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA
Andere Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA01
Albumintannat
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA02
Ceratonia
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA03
Calcium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA04
Racecadotril
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA51
Albumintannat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A08
Abmagerungsmittel, Exkl. Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A08A
Abmagerungsmittel, Exkl. Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA
Zentral wirkende Abmagerungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA01
Phentermin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA02
Fenfluramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA03
Amfepramon
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA04
Dexfenfluramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA05
Mazindol
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA06
Etilamfetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA07
Cathin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA08
Clobenzorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA09
Mefenorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA10
Sibutramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA56
Ephedrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB
Peripher wirkende Abmagerungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB01
Orlistat
WHO Anatomical Therapeutic Chemical classification
0‑L
A09
Digestiva, Inkl. Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
A09A
Digestiva, Inkl. Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA
Enzym-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA01
Diastase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA02
Multienzyme (Lipase, Protease etc.)
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA03
Pepsin
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA04
Tilactase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB
Säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB01
Glutaminsäurehydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB02
Betainhydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB03
Salzsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB04
Zitronensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC
Enzym- und Säure-haltige Zubereitungen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC01
Pepsin- und Säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC02
Multienzyme und säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10
Antidiabetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A10A
Insuline Und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AA
Insulins
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB
Insuline und Analoga zur Injektion, schnell wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB05
Insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB06
Insulin glulisin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC
Insuline und Analoga zur Injektion, intermediär wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD
Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD05
Insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE
Insuline und Analoga zur Injektion, lang wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE04
Insulin glargin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE05
Insulin detemir
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF
Insuline und Analoga zur Inhalation
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10B
Antidiabetika, Exkl. Insuline
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA
Biguanide
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA01
Phenformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA02
Metformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA03
Buformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB
Sulfonylharnstoff-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB01
Glibenclamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB02
Chlorpropamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB03
Tolbutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB04
Glibornurid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB05
Tolazamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB06
Carbutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB07
Glipizid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB08
Gliquidon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB09
Gliclazid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB10
Metahexamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB11
Glisoxepid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB12
Glimepirid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB31
Acetohexamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BC
Sulfonamide (heterozyklisch)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BC01
Glymidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD
Kombinationen mit oralen Antidiabetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD01
Phenformin und Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD02
Metformin und Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD03
Metformin und Rosiglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD04
Glimepirid und Rosiglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD05
Metformin und Pioglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD06
Glimepirid und Pioglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD07
Metformin und Sitagliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD08
Metformin und Vildagliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BD13
Metformin und Alogliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BF
Alpha-Glukosidasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BF01
Acarbose
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BF02
Miglitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BF03
Voglibose
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BG
Thiazolidindione
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BG01
Troglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BG02
Rosiglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BG03
Pioglitazon
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BH01
Sitagliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BH02
Vildagliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BH04
Alogliptin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BX
Andere Antidiabetika, exkl. Insuline
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BX01
Guar-Mehl
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BX02
Repaglinid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BX03
Nateglinid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BX04
Exenatid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10X
Andere Antidiabetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A10XA
Aldosereduktasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A10XA01
Tolrestat
WHO Anatomical Therapeutic Chemical classification
0‑L
A11
Vitamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A11A
Multivitamine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AA
Multivitamine mit Mineralstoffen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AA01
Multivitamine und Eisen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AA02
Multivitamine und Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AA03
Multivitamine und andere Mineralstoffe, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AA04
Multivitamine und Spurenelemente
WHO Anatomical Therapeutic Chemical classification
0‑L
A11AB
Multivitamine, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11B
Multivitamine, Rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11BA
Multivitamine, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11C
Vitamin A und D, inkl. deren Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CA
Vitamin A, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CA01
Retinol (Vitamin A)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CA02
Betacaroten
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CB
Vitamin A und D in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC
Vitamin D und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC01
Ergocalciferol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC02
Dihydrotachysterol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC03
Alfacalcidol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC04
Calcitriol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC05
Colecalciferol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC06
Calcifediol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC07
Paricalcitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11CC20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11D
Vitamin-B1, rein und in Kombination mit Vitamin-B6 und Vitamin-B12
WHO Anatomical Therapeutic Chemical classification
0‑L
A11DA
Vitamin-B1, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11DA01
Thiamin (Vitamin-B1)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11DA02
Sulbutiamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A11DA03
Benfotiamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A11DB
Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12
WHO Anatomical Therapeutic Chemical classification
0‑L
A11E
Vitamin-B-Komplex, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11EA
Vitamin-B-Komplex, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11EB
Vitamin-B-Komplex mit Vitamin C
WHO Anatomical Therapeutic Chemical classification
0‑L
A11EC
Vitamin-B-Komplex mit Mineralstoffen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11ED
Vitamin-B-Komplex mit anabolen Steroiden
WHO Anatomical Therapeutic Chemical classification
0‑L
A11EX
Vitamin-B-Komplex, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11G
Ascorbinsäure (Vitamin C), inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11GA
Ascorbinsäure (Vitamin C), rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11GA01
Ascorbinsäure (Vitamin C)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11GB
Ascorbinsäure (Vitamin C), Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11GB01
Ascorbinsäure (Vitamin C) und Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A11H
Andere Vitaminpräparate, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA
Andere Vitaminpräparate, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA01
Nicotinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA02
Pyridoxin (Vitamin-B6)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA03
Tocopherol (Vitamin E)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA04
Riboflavin (Vitamin-B2)
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA05
Biotin
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA06
Pyridoxalphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA07
Inositol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA30
Dexpanthenol
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA31
Calciumpantothenat
WHO Anatomical Therapeutic Chemical classification
0‑L
A11HA32
Pantethin
WHO Anatomical Therapeutic Chemical classification
0‑L
A11J
Andere Vitaminpräparate, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11JA
Kombinationen von Vitaminen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11JB
Vitamine mit Mineralstoffen
WHO Anatomical Therapeutic Chemical classification
0‑L
A11JC
Vitamine, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A12
Mineralstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
A12A
Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA
Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA01
Calciumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA02
Calciumglubionat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA03
Calciumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA04
Calciumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA05
Calciumlactat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA06
Calciumlactogluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA07
Calciumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA08
Calciumglycerylphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA09
Calciumcitratlysin-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA10
Calciumglucoheptonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA11
Calciumpangamat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA12
Calciumacetat, wasserfrei
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA20
Calcium (verschiedene Salze in Kombination)
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AA30
Calciumlaevulat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AX
Calcium, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
A12AX01
Calciumcarbonat und Colecalciferol
WHO Anatomical Therapeutic Chemical classification
0‑L
A12B
Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA
Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA01
Kaliumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA02
Kaliumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA03
Kaliumhydrogentartrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA04
Kaliumhydrogencarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA05
Kaliumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A12BA51
Kaliumchlorid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A12C
Andere Mineralstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CA
Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CA01
Natriumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CA02
Natriumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CB
Zink
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CB01
Zinksulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CB02
Zinkgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CB03
Zinkprotein-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC
Magnesium
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC01
Magnesiumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC02
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC03
Magnesiumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC04
Magnesiumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC05
Magnesiumaspartat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC06
Magnesiumlactat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC07
Magnesiumlevulinat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC08
Magnesiumpidolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC09
Magnesiumorotat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC10
Magnesiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC11
Magnesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CC30
Magnesium (verschiedene Salze in Kombination)
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CD
Fluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CD01
Natriumfluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CD02
Natriummonofluorphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CD51
Natriumfluorid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CE
Selen
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CE01
Natriumselenat
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CE02
Natriumselenit
WHO Anatomical Therapeutic Chemical classification
0‑L
A12CX
Andere Mineralstoff-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A13
Tonika
WHO Anatomical Therapeutic Chemical classification
0‑L
A13A
Tonika
WHO Anatomical Therapeutic Chemical classification
0‑L
A14
Anabolika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
A14A
Anabole Steroide
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA
Androstan-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA01
Androstanolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA02
Stanozolol
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA03
Metandienon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA04
Metenolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA05
Oxymetholon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA06
Quinbolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA07
Prasteron
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA08
Oxandrolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AA09
Norethandrolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AB
Estren-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AB01
Nandrolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AB02
Ethylestrenol
WHO Anatomical Therapeutic Chemical classification
0‑L
A14AB03
Oxaboloncipionat
WHO Anatomical Therapeutic Chemical classification
0‑L
A14B
Andere Anabolika
WHO Anatomical Therapeutic Chemical classification
0‑L
A15
Appetit stimulierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A16
Andere Mittel für das alimentäre System und den Stoffwechsel
WHO Anatomical Therapeutic Chemical classification
0‑L
A16A
Andere Mittel für das alimentäre System und den Stoffwechsel
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA
Aminosäuren und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA01
Levocarnitin
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA02
Ademetionin
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA03
Glutamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA04
Mercaptamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA05
Carglumsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AA06
Betain
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB01
Alglucerase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB02
Imiglucerase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB03
Agalsidase alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB04
Agalsidase beta
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB05
Laronidase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB06
Sacrosidase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB07
Alglucosidase alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB08
Galsulfase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB09
Idursulfase
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AB10
Velaglucerase Alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX
Sonstige Mittel für das alimentäre System und den Stoffwechsel
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX01
Alpha-Liponsäure (Thioctsäure)
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX02
Anetholtrithion
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX03
Natriumphenylbutyrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX04
Nitisinon
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX05
Zinkacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX06
Miglustat
WHO Anatomical Therapeutic Chemical classification
0‑L
A16AX07
Sapropterin
WHO Anatomical Therapeutic Chemical classification
0‑L
B
Blut und Blut bildende Organe
WHO Anatomical Therapeutic Chemical classification
0‑L
B01
Antithrombotische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
B01A
Antithrombotische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA
Vitamin-K-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA01
Dicoumarol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA02
Phenindion
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA03
Warfarin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA04
Phenprocoumon
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA07
Acenocoumarol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA08
Ethylbiscoumacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA09
Clorindion
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA10
Diphenadion
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AA11
Tioclomarol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB
Heparingruppe
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB01
Heparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB02
Antithrombin III
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB04
Dalteparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB05
Enoxaparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB06
Nadroparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB07
Parnaparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB08
Reviparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB09
Danaparoid
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB10
Tinzaparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB11
Sulodexid
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB12
Bemiparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AB51
Heparin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC
Thrombozytenaggregationshemmer, exkl. Heparin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC01
Ditazol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC02
Cloricromen
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC03
Picotamid
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC04
Clopidogrel
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC05
Ticlopidin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC06
Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC07
Dipyridamol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC08
Carbasalatcalcium
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC09
Epoprostenol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC10
Indobufen
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC11
Iloprost
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC13
Abciximab
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC15
Aloxiprin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC16
Eptifibatid
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC17
Tirofiban
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC18
Triflusal
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC19
Beraprost
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC21
Treprostinil
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AC56
Acetylsalicylsäure und Esomeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD01
Streptokinase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD02
Alteplase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD03
Anistreplase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD04
Urokinase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD05
Fibrinolysin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD06
Brinase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD07
Reteplase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD08
Saruplase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD09
Ancrod
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD10
Drotrecogin alfa (aktiviert)
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD11
Tenecteplase
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AD12
Protein C
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE
Direkte Thrombininhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE01
Desirudin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE02
Lepirudin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE03
Argatroban
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE04
Melagatran
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE05
Ximelagatran
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE06
Bivalirudin
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AE07
Dabigatran etexilat
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AX
Andere antithrombotische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AX01
Defibrotid
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AX04
Chondroitinsulfat B
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AX05
Fondaparinux
WHO Anatomical Therapeutic Chemical classification
0‑L
B01AX06
Rivaroxaban
WHO Anatomical Therapeutic Chemical classification
0‑L
B02
Antihämorrhagika
WHO Anatomical Therapeutic Chemical classification
0‑L
B02A
Antifibrinolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AA
Aminosäuren
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AA01
Aminocapronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AA02
Tranexamsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AA03
Aminomethylbenzoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AB
Proteinasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AB01
Aprotinin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AB02
Alfa1-Antitrypsin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AB03
C1-Inhibitor
WHO Anatomical Therapeutic Chemical classification
0‑L
B02AB04
Camostat
WHO Anatomical Therapeutic Chemical classification
0‑L
B02B
Vitamin K und andere Hämostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BA
Vitamin K
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BA01
Phytomenadion
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BA02
Menadion
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BB
Fibrinogene
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BB01
Fibrinogen, human
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC
Lokale Hämostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC01
Absorbierbarer Gelatineschwamm
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC02
Oxidierte Zellulose
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC03
Tetragalacturonsäurehydroxymethylester
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC05
Adrenalon
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC06
Thrombin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC07
Kollagen
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC08
Calciumalginat
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC09
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC10
Fibrinogen, human
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD
Blutgerinnungsfaktoren
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD01
Gerinnungsfaktoren IX, II, VII und X in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD02
Gerinnungsfaktor VIII
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD03
Faktor-VIII-Inhibitor bypass Aktivität
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD04
Gerinnungsfaktor IX
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD05
Gerinnungsfaktor VII
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD06
Von-Willebrand-Faktor und Gerinnungsfaktor VIII in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD07
Gerinnungsfaktor XIII
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD08
Eptacog alfa (aktiviert)
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD09
Nonacog alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD10
von-Willebrand-Faktor
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BD30
Thrombin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX
Andere systemische Hämostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX01
Etamsylat
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX02
Carbazochrom
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX03
Batroxobin
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX04
Romiplostim
WHO Anatomical Therapeutic Chemical classification
0‑L
B02BX05
Eltrombopag
WHO Anatomical Therapeutic Chemical classification
0‑L
B03
Antianämika
WHO Anatomical Therapeutic Chemical classification
0‑L
B03A
Eisen-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA
Eisen zweiwertig, orale Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA01
Eisen(II)-Glycinsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA02
Eisen(II)fumarat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA03
Eisen(II)gluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA04
Eisen(II)carbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA05
Eisen(II)chlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA06
Eisen(II)succinat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA07
Eisen(II)sulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA08
Eisen(II)tartrat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA09
Eisen(II)aspartat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA10
Eisen(II)ascorbat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AA11
Eisen(II)iodat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB
Eisen dreiwertig, orale Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB01
Eisen(III)-Natrium-citrat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB02
Eisen(III)oxid-Saccharose-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB03
Natriumferedetat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB04
Eisen(III)hydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB05
Dextriferron
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB06
Eisen(III)citrat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB07
Chondroitinsulfat-Eisen(III)-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB08
Eisen(III)acetyltransferrin
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AB09
Eisen(III)proteinsuccinylat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC
Eisen dreiwertig, parenterale Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC01
Dextriferron
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC02
Eisen(III)oxid-Saccharose-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC03
Eisen(III)sorbit-Zitronensäure-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC05
Eisen(III)sorbit-Gluconsäure-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC06
Eisen(III)oxid-Dextran-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AC07
Eisen(III)-Natrium-Gluconat-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AD
Eisen in Kombination mit Folsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AD01
Eisen-Aminosäure-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AD02
Eisen(II)fumarat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AD03
Eisen(II)sulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AD04
Dextriferron
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE
Eisen in anderen Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE01
Eisen, Vitamin-B12 und Folsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE02
Eisen, Multivitamine und Folsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE03
Eisen und Multivitamine
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE04
Eisen, Multivitamine und Mineralstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
B03AE10
Verschiedene Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03B
Vitamin-B12 und Folsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA
Vitamin-B12 (Cyanocobalamin und Analoga)
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA01
Cyanocobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA02
Cyanocobalamin-Tannin-Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA03
Hydroxocobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA04
Cobamamid
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA05
Mecobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA51
Cyanocobalamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BA53
Hydroxocobalamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BB
Folsäure und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BB01
Folsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B03BB51
Folsäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B03X
Andere Antianämika
WHO Anatomical Therapeutic Chemical classification
0‑L
B03XA
Andere Antianämika
WHO Anatomical Therapeutic Chemical classification
0‑L
B03XA01
Erythropoietin
WHO Anatomical Therapeutic Chemical classification
0‑L
B03XA02
Darbepoetin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
B03XA03
Methoxy-Polyethylenglycol-Epoetin beta
WHO Anatomical Therapeutic Chemical classification
0‑L
B05
Blutersatzmittel und Perfusionslösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05A
Blut und verwandte Produkte
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA
Blutersatzmittel und Plasmaproteinfraktionen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA01
Albumin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA02
Andere Plasmaproteinfraktionen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA03
Fluorocarbon-Blutersatzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA05
Dextran
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA06
Gelatine-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA07
Hydroxyethylstärke
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA08
Hämoglobin crosfumaril
WHO Anatomical Therapeutic Chemical classification
0‑L
B05AA09
Haemoglobin raffimer
WHO Anatomical Therapeutic Chemical classification
0‑L
B05B
I.V.-Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA
Lösungen zur parenteralen Ernährung
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA01
Aminosäuren
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA02
Fett-Emulsionen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA03
Kohlenhydrate
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA04
Proteinhydrolysate
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BA10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BB
Lösungen mit Wirkung auf den Elektrolythaushalt
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BB01
Elektrolyte
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BB02
Elektrolyte mit Kohlenhydraten
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BB03
Trometamol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BC
Osmodiuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BC01
Mannitol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05BC02
Harnstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
B05C
Spüllösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA01
Cetylpyridinium
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA02
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA03
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA04
Sulfamethizol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA05
Taurolidin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA06
Mandelsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA07
Noxytiolin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA08
Ethacridinlactat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA09
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CA10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB
Salzlösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB01
Natriumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB02
Natriumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB03
Magnesiumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB04
Natriumbicarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CB10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX
Andere Spüllösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX01
Glucose
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX02
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX03
Glycin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX04
Mannitol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05CX10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05D
LÖSUNGEN ZUR PERITONEALDIALYSE
WHO Anatomical Therapeutic Chemical classification
0‑L
B05DA
Isotone Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05DB
Hypertone Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05X
ADDITIVA ZU I.V.-LÖSUNGEN
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA
Elektrolytlösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA01
Kaliumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA02
Natriumbicarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA03
Natriumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA04
Ammoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA05
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA06
Kaliumphosphat, inkl. Kombinationen mit anderen Kaliumsalzen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA07
Calciumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA08
Natriumacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA09
Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA10
Magnesiumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA11
Magnesiumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA12
Zinkchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA13
Salzsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA14
Dinatrium-1-glycerinphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA15
Kaliumlactat
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA16
Kardioplege Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA30
Kombinationen von Elektrolyten
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XA31
Elektrolyte in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XB
Aminosäuren
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XB01
Argininhydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XB02
Alanylglutamin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XB03
Lysin
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XC
Vitamine
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XX
Andere Additiva zu i.v.-Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
B05XX02
Trometamol
WHO Anatomical Therapeutic Chemical classification
0‑L
B05Z
Hämodialysekonzentrate und Hämofiltrate
WHO Anatomical Therapeutic Chemical classification
0‑L
B05ZA
Hämodialysekonzentrate
WHO Anatomical Therapeutic Chemical classification
0‑L
B05ZB
Hämofiltrate
WHO Anatomical Therapeutic Chemical classification
0‑L
B06
Andere Hämatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
B06A
Andere Hämatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA02
Fibrinolysin und Desoxyribonuclease
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA03
Hyaluronidase
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA04
Chymotrypsin
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA07
Trypsin
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA10
Desoxyribonuclease
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA11
Bromelaine
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AA55
Streptokinase, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AB
Andere Hämprodukte
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AB01
Hematin
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AC01
C1-Inhibitor, plasma derived
WHO Anatomical Therapeutic Chemical classification
0‑L
B06AC04
Conestat alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
C
Kardiovaskuläres System
WHO Anatomical Therapeutic Chemical classification
0‑L
C01
Herztherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
C01A
Herzglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA
Digitalisglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA01
Acetyldigitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA02
Acetyldigoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA03
Digitalisblätter
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA04
Digitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA05
Digoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA06
Lanatosid C
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA07
Deslanosid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA08
Metildigoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA09
Gitoformat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AA52
Acetyldigoxin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AB
Scillaglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AB01
Proscillaridin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AB51
Proscillaridin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AC
Strophanthusglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AC01
g-Strophanthin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AC03
Cymarin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AX
Andere Herzglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01AX02
Peruvosid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01B
Antiarrhythmika, Klasse I und III
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA
Antiarrhythmika, Klasse Ia
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA01
Chinidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA02
Procainamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA03
Disopyramid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA04
Spartein
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA05
Ajmalin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA08
Prajmalin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA12
Lorajmin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA51
Chinidin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BA71
Chinidin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BB
Antiarrhythmika, Klasse Ib
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BB01
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BB02
Mexiletin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BB03
Tocainid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BB04
Aprindin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BC
Antiarrhythmika, Klasse Ic
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BC03
Propafenon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BC04
Flecainid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BC07
Lorcainid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BC08
Encainid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD
Antiarrhythmika, Klasse III
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD01
Amiodaron
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD02
Bretyliumtosilat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD03
Bunaftin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD04
Dofetilid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BD05
Ibutilid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BG
Andere Klasse-I-Antiarrhythmika
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BG01
Moracizin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BG07
Cibenzolin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01BG11
Vernakalant
WHO Anatomical Therapeutic Chemical classification
0‑L
C01C
Kardiostimulanzien, Exkl. Herzglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA
Adrenerge und dopaminerge Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA01
Etilefrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA02
Isoprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA03
Norepinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA04
Dopamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA05
Norfenefrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA06
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA07
Dobutamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA08
Oxedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA09
Metaraminol
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA10
Methoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA11
Mephentermin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA12
Dimetofrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA13
Prenalterol
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA14
Dopexamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA15
Gepefrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA16
Ibopamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA17
Midodrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA18
Octopamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA19
Fenoldopam
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA21
Cafedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA22
Arbutamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA23
Theodrenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA24
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA26
Ephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CA51
Etilefrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CE
Phosphodiesterasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CE01
Amrinon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CE02
Milrinon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CE03
Enoximon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CE04
Bucladesin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CX
Andere Kardiostimulanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CX06
Angiotensinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CX07
Xamoterol
WHO Anatomical Therapeutic Chemical classification
0‑L
C01CX08
Levosimendan
WHO Anatomical Therapeutic Chemical classification
0‑L
C01D
Bei Herzerkrankungen Eingesetzte Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA
Organische Nitrate
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA02
Glyceroltrinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA04
Methylpropylpropanedioldinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA05
Pentaerythrityltetranitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA07
Propatylnitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA08
Isosorbiddinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA09
Trolnitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA13
Erythrityltetranitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA14
Isosorbidmononitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA20
Organische Nitrate in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA38
Tenitramin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA52
Glyceroltrinitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA54
Methylpropylpropanedioldinitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA55
Pentaerythrityltetranitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA57
Propatylnitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA58
Isosorbiddinitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA59
Trolnitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA63
Erythrityltetranitrat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DA70
Organische Nitrate in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DB
Chinolon-Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DB01
Flosequinan
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX
Andere bei Herzerkrankungen eingesetzte Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX01
Itramintosilat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX02
Prenylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX03
Oxyfedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX04
Benziodaron
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX05
Carbocromen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX06
Hexobendin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX07
Etafenon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX08
Heptaminol
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX09
Imolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX10
Dilazep
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX11
Trapidil
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX12
Molsidomin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX13
Efloxat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX14
Cinepazet
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX15
Cloridarol
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX16
Nicorandil
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX18
Linsidomin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX19
Nesiritid
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX51
Itramintosilat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX52
Prenylamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX53
Oxyfedrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01DX54
Benziodaron, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01E
Andere Herzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EA
Prostaglandine
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EA01
Alprostadil
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB
Andere Herzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB02
Campher
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB03
Indometacin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB04
Crataegus-Glykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB05
Creatinolfosfat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB06
Fosfocreatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB07
Fructose-1,6-diphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB09
Ubidecarenon
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB10
Adenosin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB11
Tiracizin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB12
Tedisamil
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB13
Acadesin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB15
Trimetazidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB16
Ibuprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB17
Ivabradin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB18
Ranolazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EB21
Regadenoson
WHO Anatomical Therapeutic Chemical classification
0‑L
C01EX
Andere Herzmittel, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02
Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02A
Antiadrenerge Mittel, zentral wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA
Rauwolfia-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA01
Rescinnamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA02
Reserpin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA03
Kombinationen von Rauwolfia-Alkaloiden
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA04
Rauwolfia-Alkaloide, ganze Wurzel
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA05
Deserpidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA06
Methoserpidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA07
Bietaserpin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA52
Reserpin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA53
Kombinationen von Rauwolfia-Alkaloiden, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AA57
Bietaserpin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AB
Methyldopa
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AB01
Methyldopa (linksdrehend)
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AB02
Methyldopa (racemisch)
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC
Imidazolin-Rezeptoragonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC01
Clonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC02
Guanfacin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC04
Tolonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC05
Moxonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02AC06
Rilmenidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02B
Antiadrenerge Mittel, Ganglienblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C02BA
Sulfonium-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02BA01
Trimetaphan
WHO Anatomical Therapeutic Chemical classification
0‑L
C02BB
Sekundäre und tertiäre Amine
WHO Anatomical Therapeutic Chemical classification
0‑L
C02BB01
Mecamylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02BC
Bisquartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02C
Antiadrenerge Mittel, peripher wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA
Alpha-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA01
Prazosin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA02
Indoramin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA03
Trimazosin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA04
Doxazosin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CA06
Urapidil
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC
Guanidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC01
Betanidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC02
Guanethidin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC03
Guanoxan
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC04
Debrisoquin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC05
Guanoclor
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC06
Guanazodin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02CC07
Guanoxabenz
WHO Anatomical Therapeutic Chemical classification
0‑L
C02D
mittel mit Wirkung auf die arterielle Gefässmuskulatur
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DA
Thiazid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DA01
Diazoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DB
Hydrazinophthalazin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DB01
Dihydralazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DB02
Hydralazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DB03
Endralazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DB04
Cadralazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DC
Pyrimidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DC01
Minoxidil
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DD
Nitroferrocyanid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DD01
Nitroprussid
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DF
Non-thiazide sulfonamides
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DG
Guanidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C02DG01
Pinacidil
WHO Anatomical Therapeutic Chemical classification
0‑L
C02K
Andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KA
Alkaloide, exkl. Rauwolfia
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KA01
Veratrum
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KB
Tyrosinhydroxylasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KB01
Metirosin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KC
MAO-Hemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KC01
Pargylin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KD
Serotonin-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KD01
Ketanserin
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KX
Andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KX01
Bosentan
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KX02
Ambrisentan
WHO Anatomical Therapeutic Chemical classification
0‑L
C02KX03
Sitaxentan
WHO Anatomical Therapeutic Chemical classification
0‑L
C02L
Antihypertonika und Diuretika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA
Rauwolfia-Alkaloide und Diuretika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA01
Reserpin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA02
Rescinnamin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA03
Deserpidin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA04
Methoserpidin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA07
Bietaserpin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA08
Rauwolfia-Alkaloide, ganze Wurzel und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA09
Syrosingopin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA50
Kombinationen von Rauwolfia-Alkaloiden und Diuretika inkl. andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA51
Reserpin und Diuretika, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA52
Rescinnamin und Diuretika, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LA71
Reserpin und Diuretika, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LB
Methyldopa und Diuretika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LB01
Methyldopa (linksdrehend) und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LC
Imidazolin-Rezeptoragonisten in Kombination mit Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LC01
Clonidin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LC05
Moxonidin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LC51
Clonidin und Diuretika, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LE
Alpha-Adrenorezeptor-Antagonisten und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LE01
Prazosin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LF
Guanidin-Derivate und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LF01
Guanethidin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG
Hydrazinophthalazin-Derivate und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG01
Dihydralazin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG02
Hydralazin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG03
Picodralazin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG51
Dihydralazin und Diuretika, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LG73
Picodralazin und Diuretika, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LI
Calcium channel blockers and diuretics
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LK
Alkaloide, exkl. Rauwolfia, in Kombination mit Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LK01
Veratrum und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LL
MAO-Hemmer und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LL01
Pargylin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LN
Serotonin-Antagonisten und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LX
Andere Antihypertonika und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02LX01
Pinacidil und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C02N
Kombinationen von antihypertensiven Wirkstoffen aus ATC-Gruppe C02
WHO Anatomical Therapeutic Chemical classification
0‑L
C03
Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03A
Low-Ceiling-Diuretika, Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA
Thiazide, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA01
Bendroflumethiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA02
Hydroflumethiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA03
Hydrochlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA04
Chlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA05
Polythiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA06
Trichlormethiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA07
Cyclopenthiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA08
Methylclothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA09
Cyclothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AA13
Mebutizid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB
Thiazide und Kalium in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB01
Bendroflumethiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB02
Hydroflumethiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB03
Hydrochlorothiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB04
Chlorothiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB05
Polythiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB06
Trichlormethiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB07
Cyclopenthiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB08
Methylclothiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AB09
Cyclothiazid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AH
Thiazide, Kombinationen mit Psycholeptika und/oder Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AH01
Chlorothiazid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AH02
Hydroflumethiazid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AX
Thiazide, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C03AX01
Hydrochlorothiazid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C03B
Low-Ceiling-Diuretika, exkl. Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA
Sulfonamide, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA02
Quinethazon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA03
Clopamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA04
Chlortalidon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA05
Mefrusid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA07
Clofenamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA08
Metolazon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA09
Meticran
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA10
Xipamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA11
Indapamid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA12
Clorexolon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA13
Fenquizon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BA82
Clorexolon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB
Sulfonamide und Kalium in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB02
Quinethazon und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB03
Clopamid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB04
Chlortalidon und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB05
Mefrusid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BB07
Clofenamid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BC
Quecksilber-haltige Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BC01
Mersalyl
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BD
Xanthin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BD01
Theobromin
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BK
Sulfonamide, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BX
Andere Low-ceiling-Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03BX03
Cicletanin
WHO Anatomical Therapeutic Chemical classification
0‑L
C03C
High-Ceiling-Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CA
Sulfonamide, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CA01
Furosemid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CA02
Bumetanid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CA03
Piretanid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CA04
Torasemid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CB
Sulfonamide und Kalium in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CB01
Furosemid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CB02
Bumetanid und Kalium
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CC
Aryloxyessigsäure-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CC01
Etacrynsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CC02
Tienilinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CD
Pyrazolon-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CD01
Muzolimin
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CX
Andere High-ceiling-Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03CX01
Etozolin
WHO Anatomical Therapeutic Chemical classification
0‑L
C03D
Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DA
Aldosteron-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DA01
Spironolacton
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DA02
Kaliumcanrenoat
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DA03
Canrenon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DA04
Eplerenon
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DB
Andere Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DB01
Amilorid
WHO Anatomical Therapeutic Chemical classification
0‑L
C03DB02
Triamteren
WHO Anatomical Therapeutic Chemical classification
0‑L
C03E
Diuretika und Kalium sparende Mittel in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA
Low-ceiling-Diuretika und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA01
Hydrochlorothiazid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA02
Trichlormethiazid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA03
Epitizid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA04
Altizid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA05
Mebutizid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA06
Chlortalidon und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA07
Cyclopenthiazid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA12
Metolazon und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA13
Bendroflumethiazid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EA14
Butizid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EB
High-ceiling-Diuretika und Kalium sparende Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EB01
Furosemid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C03EB02
Bumetanid und Kalium sparende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C04
Periphere Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C04A
Periphere Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AA
2-Amino-1-phenylethanol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AA01
Isoxsuprin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AA02
Buphenin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AA31
Bamethan
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AB
Imidazolin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AB01
Phentolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AB02
Tolazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AC
Nicotinsäure und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AC01
Nicotinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AC02
Nicotinylalkohol (Pyridylcarbinol)
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AC03
Inositolnicotinat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AC07
Ciclonicat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AD
Purin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AD01
Pentifyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AD02
Xantinolnicotinat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AD03
Pentoxifyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AD04
Etofyllinnicotinat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE
Mutterkorn-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE01
Ergoloidmesylat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE02
Nicergolin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE04
Dihydroergocristin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE51
Ergoloidmesylat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AE54
Dihydroergocristin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AF
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AF01
Kallidinogenase
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX
Andere periphere Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX01
Cyclandelat
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX02
Phenoxybenzamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX07
Vincamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX10
Moxisylyt
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX11
Bencyclan
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX17
Vinburnin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX19
Suloctidil
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX20
Buflomedil
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX21
Naftidrofuryl
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX23
Butalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX24
Visnadin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX26
Cetiedil
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX27
Cinepazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX28
Ifenprodil
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX30
Azapetin
WHO Anatomical Therapeutic Chemical classification
0‑L
C04AX32
Fasudil
WHO Anatomical Therapeutic Chemical classification
0‑L
C05
Vasoprotektoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C05A
Hämorrhoidenmittel zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA
Corticosteroid-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA01
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA04
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA05
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA06
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA08
Fluocortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA09
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA10
Fluocinolonacetonid
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AA11
Fluocinonid
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AB
Antibiotika-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD
Lokalanästhetika-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD01
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD02
Tetracain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD03
Benzocain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD04
Cinchocain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD05
Procain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD06
Oxetacain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AD07
Pramocain
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AE01
Glyceroltrinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX
Andere Hämorrhoidenmittel zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX01
Aluminium-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX02
Bismutpräparate, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX03
Andere Hämorrhoidenmittel, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX04
Zinkpräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
C05AX05
Tribenosid
WHO Anatomical Therapeutic Chemical classification
0‑L
C05B
Antivarikosa
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA
Heparine oder Heparinoide zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA01
Heparinoide
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA02
Natriumapolat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA03
Heparin
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA04
Natriumpentosanpolysulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA51
Heparinoid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BA53
Heparin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB
Sklerosierende Mittel zur lokalen Injektion
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB01
Monoethanolaminoleat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB02
Polidocanol
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB03
Invertzucker
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB04
Natriumtetradecylsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB05
Phenol
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BB56
Glucose, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BX
Andere sklerosierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BX01
Calciumdobesilat
WHO Anatomical Therapeutic Chemical classification
0‑L
C05BX51
Calciumdobesilat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05C
Kapillarstabilisierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA
Bioflavonoide
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA01
Rutoside
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA02
Monoxerutin
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA03
Diosmin
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA04
Troxerutin
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA05
Hidrosmin
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA51
Rutosid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA53
Diosmin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CA54
Troxerutin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CP02
Weinlaubblätter
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CX
Andere kapillarstabilisierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C05CX01
Tribenosid
WHO Anatomical Therapeutic Chemical classification
0‑L
C07
Beta-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C07A
Beta-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA01
Alprenolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA02
Oxprenolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA03
Pindolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA05
Propranolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA06
Timolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA07
Sotalol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA12
Nadolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA14
Mepindolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA15
Carteolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA16
Tertatolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA17
Bopindolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA19
Bupranolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA23
Penbutolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA27
Cloranolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AA57
Sotalol, Kombinationspackungen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB
Beta-Adrenorezeptor-Antagonisten, selektiv
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB01
Practolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB02
Metoprolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB03
Atenolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB04
Acebutolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB05
Betaxolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB06
Bevantolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB07
Bisoprolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB08
Celiprolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB09
Esmolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB10
Epanolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB11
S-Atenolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB12
Nebivolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB13
Talinolol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB52
Metoprolol, Kombinationspackungen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AB57
Bisoprolol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AG
Alpha- und Beta-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AG01
Labetalol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07AG02
Carvedilol
WHO Anatomical Therapeutic Chemical classification
0‑L
C07B
Beta-Adrenorezeptor-Antagonisten und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA02
Oxprenolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA05
Propranolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA06
Timolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA07
Sotalol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA12
Nadolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BA68
Metipranolol und Thiazide, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB
Beta-Adrenorezeptor-Antagonisten, selektiv, und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB02
Metoprolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB03
Atenolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB04
Acebutolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB06
Bevantolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB07
Bisoprolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB12
Nebivolol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BB52
Metoprolol und Thiazide, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BG
Alpha- und Beta-Adrenorezeptor-Antagonisten und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07BG01
Labetalol und Thiazide
WHO Anatomical Therapeutic Chemical classification
0‑L
C07C
Beta-Adrenorezeptor-Antagonisten und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CA02
Oxprenolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CA03
Pindolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CA17
Bopindolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CA23
Penbutolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CB
Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CB02
Metoprolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CB03
Atenolol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CB53
Atenolol und andere Diuretika, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CG
Alpha- und Beta-Adrenorezeptor-Antagonisten und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07CG01
Labetalol und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07D
Beta-Adrenorezeptor-Antagonisten, Thiazide und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07DA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv, Thiazide und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07DA06
Timolol, Thiazide und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07DB
Beta-Adrenorezeptor-Antagonisten, selektiv, Thiazide und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07DB01
Atenolol, Thiazide und andere Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07E
Beta-Adrenorezeptor-Antagonisten und Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C07EA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C07EB
Beta-Adrenorezeptor-Antagonisten, selektiv, und Vasodilatatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C07F
Beta-Adrenorezeptor-Antagonisten und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07FA
Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07FA05
Propranolol und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07FB
Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07FB02
Metoprolol und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C07FB03
Atenolol und andere Antihypertonika
WHO Anatomical Therapeutic Chemical classification
0‑L
C08
Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C08C
Selektive Calciumkanalblocker mit vorwiegender Gefässwirkung
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA
Dihydropyridin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA01
Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA02
Felodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA03
Isradipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA04
Nicardipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA05
Nifedipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA06
Nimodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA07
Nisoldipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA08
Nitrendipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA09
Lacidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA10
Nilvadipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA11
Manidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA12
Barnidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA13
Lercanidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA14
Cilnidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA15
Benidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA16
Clevidipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CA55
Nifedipin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CX
Andere selektive Calciumkanalblocker mit vorwiegender Gefässwirkung
WHO Anatomical Therapeutic Chemical classification
0‑L
C08CX01
Mibefradil
WHO Anatomical Therapeutic Chemical classification
0‑L
C08D
Selektive Calciumkanalblocker mit direkter Herzwirkung
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DA
Phenylalkylamin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DA01
Verapamil
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DA02
Gallopamil
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DA51
Verapamil, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DB
Benzothiazepin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C08DB01
Diltiazem
WHO Anatomical Therapeutic Chemical classification
0‑L
C08E
Nichtselektive Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EA
Phenylalkylamin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EA01
Fendilin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EA02
Bepridil
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EX
Andere nichtselektive Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EX01
Lidoflazin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08EX02
Perhexilin
WHO Anatomical Therapeutic Chemical classification
0‑L
C08G
Calciumkanalblocker und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C08GA
Calciumkanalblocker und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C08GA01
Nifedipin und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09
Mittel mit Wirkung auf das Renin-Angiotensin-System
WHO Anatomical Therapeutic Chemical classification
0‑L
C09A
ACE-Hemmer, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA
ACE-Hemmer, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA01
Captopril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA02
Enalapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA03
Lisinopril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA04
Perindopril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA05
Ramipril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA06
Quinapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA07
Benazepril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA08
Cilazapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA09
Fosinopril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA10
Trandolapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA11
Spirapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA12
Delapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA13
Moexipril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA14
Temocapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA15
Zofenopril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09AA16
Imidapril
WHO Anatomical Therapeutic Chemical classification
0‑L
C09B
ACE-Hemmer, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA
ACE-Hemmer und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA01
Captopril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA02
Enalapril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA03
Lisinopril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA04
Perindopril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA05
Ramipril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA06
Quinapril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA07
Benazepril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA08
Cilazapril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA09
Fosinopril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA12
Delapril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA13
Moexipril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BA15
Zofenopril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB
ACE-Hemmer und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB02
Enalapril und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB03
Lisinopril und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB04
Perindopril und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB05
Ramipril und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB07
Ramipril und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB10
Trandolapril und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09BB12
Delapril und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09C
Angiotensin-Ii-Antagonisten, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA
Angiotensin-II-Antagonisten, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA01
Losartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA02
Eprosartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA03
Valsartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA04
Irbesartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA05
Tasosartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA06
Candesartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA07
Telmisartan
WHO Anatomical Therapeutic Chemical classification
0‑L
C09CA08
Olmesartan medoxomil
WHO Anatomical Therapeutic Chemical classification
0‑L
C09D
Angiotensin-II-Antagonisten, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA
Angiotensin-II-Antagonisten und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA01
Losartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA02
Eprosartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA03
Valsartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA04
Irbesartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA06
Candesartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA07
Telmisartan und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DA08
Olmesartan medoxomil und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DB
Angiotensin-II-Antagonisten und Calciumkanalblocker
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DB01
Valsartan und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DB02
Olmesartanmedoxomil und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DB04
Telmisartan/Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DX01
Valsartan, Amlodipin und Hydrochlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C09DX03
Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C09X
Andere Mittel mit Wirkung auf das Renin-Angiotensin-System
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA
Renin-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA01
Remikiren
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA02
Aliskiren
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA52
Aliskiren und Hydrochlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA53
Aliskiren und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
C09XA54
Aliskiren, Amlodipin und Hydrochlorothiazid
WHO Anatomical Therapeutic Chemical classification
0‑L
C10
Mittel, die den Lipidstoffwechsel beeinflussen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10A
Mittel, die den Lipidstoffwechsel beeinflussen, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA
HMG-CoA-Reduktasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA01
Simvastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA02
Lovastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA03
Pravastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA04
Fluvastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA05
Atorvastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA06
Cerivastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA07
Rosuvastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AA08
Pitavastatin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB
Fibrate
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB01
Clofibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB02
Bezafibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB03
Aluminiumclofibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB04
Gemfibrozil
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB05
Fenofibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB06
Simfibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB07
Ronifibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB08
Ciprofibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB09
Etofibrat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AB10
Clofibrid
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AC
Gallensäure bindende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AC01
Colestyramin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AC02
Colestipol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AC03
Colextran
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AC04
Colesevelam
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD
Nicotinsäure und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD01
Niceritrol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD02
Nicotinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD03
Nicofuranose
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD04
Aluminiumnicotinat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD05
Nicotinylalkohol (Pyridylcarbinol)
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD06
Acipimox
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AD52
Nicotinsäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX
Andere Mittel, die den Lipidstoffwechsel beeinflussen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX01
Dextrothyroxin
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX02
Probucol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX03
Tiadenol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX04
Benfluorex
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX05
Meglutol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX06
Omega-3-triglyceride
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX07
Magnesiumpyridoxal-5-phosphatglutamat
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX08
Policosanol
WHO Anatomical Therapeutic Chemical classification
0‑L
C10AX09
Ezetimib
WHO Anatomical Therapeutic Chemical classification
0‑L
C10B
Mittel, die den Lipidstoffwechsel beeinflussen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BA
HMG-CoA-Reduktasehemmer in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BA01
Lovastatin und Nicotinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BA02
Simvastatin und Ezetimib
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BA05
Atorvastatin und Ezetimib
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BX
HMG-CoA-Reduktasehemmer, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BX01
Simvastatin und Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BX02
Pravastatin und Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
C10BX03
Atorvastatin und Amlodipin
WHO Anatomical Therapeutic Chemical classification
0‑L
D
Dermatika
WHO Anatomical Therapeutic Chemical classification
0‑L
D01
Antimykotika zur dermatologischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D01A
Antimykotika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA01
Nystatin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA02
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA03
Hachimycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA04
Pecilocin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA06
Mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA07
Pyrrolnitrin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA08
Griseofulvin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AA20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC
Imidazol- und Triazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC01
Clotrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC02
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC03
Econazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC04
Chlormidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC05
Isoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC06
Tiabendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC07
Tioconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC08
Ketoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC09
Sulconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC10
Bifonazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC11
Oxiconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC12
Fenticonazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC13
Omoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC14
Sertaconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC15
Fluconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC16
Flutrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC52
Miconazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AC60
Bifonazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE
Andere Antimykotika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE01
Bromchlorsalicylanilid
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE02
Methylrosanilin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE03
Tribrommetacresol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE04
Undecylensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE05
Polynoxylin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE06
2-(4-chlorphenoxy)-ethanol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE07
Chlorphenesin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE08
Ticlaton
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE09
Sulbentin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE10
Ethylhydroxybenzoat
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE11
Haloprogin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE12
Salicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE13
Selendisulfid
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE14
Ciclopirox
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE15
Terbinafin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE16
Amorolfin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE17
Dimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE18
Tolnaftat
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE19
Tolciclat
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE21
Flucytosin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE22
Naftifin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE23
Butenafin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01AE54
Undecylensäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D01B
Antimykotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D01BA
Antimykotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D01BA01
Griseofulvin
WHO Anatomical Therapeutic Chemical classification
0‑L
D01BA02
Terbinafin
WHO Anatomical Therapeutic Chemical classification
0‑L
D02
Emollientia und Hautschutzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02A
Emollientia und Hautschutzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AA
Silikon-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AB
Zink-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AC
Vaseline und Fett-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AD
Flüssige Pflaster
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AE
Harnstoff-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AE01
Harnstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AE51
Harnstoff, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AF
Salicylsäure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D02AX
Andere Emollientia und Hautschutzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D02B
Protektiva gegen UV-Strahlung
WHO Anatomical Therapeutic Chemical classification
0‑L
D02BA
Protektiva gegen UV-Strahlung zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D02BA01
Aminobenzoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D02BA02
Octinoxat
WHO Anatomical Therapeutic Chemical classification
0‑L
D02BB
Protektiva gegen UV-Strahlung zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D02BB01
Betacaroten
WHO Anatomical Therapeutic Chemical classification
0‑L
D03
Zubereitungen zur Behandlung von Wunden und Geschwüren
WHO Anatomical Therapeutic Chemical classification
0‑L
D03A
Wundbehandlungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AA
Lebertransalben
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX
Andere Wundbehandlungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX01
Cadexomer-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX02
Dextranomer
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX03
Dexpanthenol
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX04
Calciumpantothenat
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX05
Hyaluronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX06
Becaplermin
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX07
Glyceroltrinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX08
Isosorbiddinitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX09
Crilanomer
WHO Anatomical Therapeutic Chemical classification
0‑L
D03AX10
Enoxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D03B
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
D03BA
Proteolytische Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
D03BA01
Trypsin
WHO Anatomical Therapeutic Chemical classification
0‑L
D03BA02
Clostridiopeptidase
WHO Anatomical Therapeutic Chemical classification
0‑L
D03BA52
Clostridiopeptidase, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D04
Antipruriginosa, inkl. Antihistaminika, Anästhetika etc.
WHO Anatomical Therapeutic Chemical classification
0‑L
D04A
Antipruriginosa, inkl. Antihistaminika, Anästhetika etc.
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA
Antihistaminika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA01
Thonzylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA02
Mepyramin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA03
Thenalidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA04
Tripelennamin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA09
Chloropyramin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA10
Promethazin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA12
Tolpropamin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA13
Dimetinden
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA14
Clemastin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA15
Bamipin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA22
Isothipendyl
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA32
Diphenhydramin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA33
Diphenhydraminmethylbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AA34
Chlorphenoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB
Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB01
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB02
Cinchocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB03
Oxybuprocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB04
Benzocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB05
Chinisocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB06
Tetracain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AB07
Pramocain
WHO Anatomical Therapeutic Chemical classification
0‑L
D04AX
Andere Antipruriginosa
WHO Anatomical Therapeutic Chemical classification
0‑L
D05
Antipsoriatika
WHO Anatomical Therapeutic Chemical classification
0‑L
D05A
Antipsoriatika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AA
Teere
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AC
Anthracen-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AC01
Dithranol
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AC51
Dithranol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AD
Psoralene zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AD01
Trioxysalen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AD02
Methoxsalen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX
Andere Antipsoriatika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX01
Fumarsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX02
Calcipotriol
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX03
Calcitriol
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX04
Tacalcitol
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX05
Tazaroten
WHO Anatomical Therapeutic Chemical classification
0‑L
D05AX52
Calcipotriol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05B
Antipsoriatika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BA
Psoralene zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BA01
Trioxysalen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BA02
Methoxsalen
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BA03
Bergapten
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BB
Retinoide zur Behandlung der Psoriasis
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BB01
Etretinat
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BB02
Acitretin
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BX
Andere Antipsoriatika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D05BX51
Fumarsäure-Derivate, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D06
Antibiotika und Chemotherapeutika zur Dermatologischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D06A
Antibiotika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AA
Tetracyclin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AA01
Demeclocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AA02
Chlortetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AA03
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AA04
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX
Andere Antibiotika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX01
Fusidinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX02
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX04
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX05
Bacitracin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX07
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX08
Tyrothricin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX09
Mupirocin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX10
Virginiamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX11
Rifaximin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX12
Amikacin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06AX13
Retapamulin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06B
Chemotherapeutika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA
Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA01
Sulfadiazin-Silber
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA02
Sulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA03
Mafenid
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA04
Sulfamethizol
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA05
Sulfanilamid
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA06
Sulfamerazin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BA51
Sulfadiazin-Silber, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB
Antivirale Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB01
Idoxuridin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB02
Tromantadin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB03
Aciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB04
Podophyllotoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB05
Inosin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB06
Penciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB07
Lysozym
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB08
Ibacitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB09
Edoxudin
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB10
Imiquimod
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB11
Docosanol
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BB53
Aciclovir, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BX
Andere Chemotherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
D06BX01
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
D06C
Antibiotika und Chemotherapeutika, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07
Corticosteroide, Dermatologische Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07A
Corticosteroide, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AA
Corticosteroide, schwach wirksam (Gruppe I)
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AA01
Methylprednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AA02
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AA03
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB
Corticosteroide, mittelstark wirksam (Gruppe II)
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB01
Clobetason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB02
Hydrocortisonbutyrat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB03
Flumetason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB04
Fluocortin
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB05
Fluperolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB06
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB07
Flupredniden
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB08
Desonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB09
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB10
Alclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB11
Hydrocortisonbuteprat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB19
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB21
Clocortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AB30
Kombinationen mittelstark wirksamer Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC
Corticosteroide, stark wirksam (Gruppe III)
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC01
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC02
Fluclorolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC03
Desoximetason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC04
Fluocinolonacetonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC05
Fluocortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC06
Diflucortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC07
Fludroxycortid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC08
Fluocinonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC09
Budesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC10
Diflorason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC11
Amcinonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC12
Halometason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC13
Mometason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC14
Methylprednisolonaceponat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC15
Beclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC16
Hydrocortisonaceponat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC17
Fluticason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC18
Prednicarbat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC19
Difluprednat
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AC21
Ulobetasol
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AD
Corticosteroide, sehr stark wirksam (Gruppe IV)
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AD01
Clobetasol
WHO Anatomical Therapeutic Chemical classification
0‑L
D07AD02
Halcinonid
WHO Anatomical Therapeutic Chemical classification
0‑L
D07B
Corticosteroide, Kombinationen mit Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BA
Corticosteroide, schwach wirksam, Kombinationen mit Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BA01
Prednisolon und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BA04
Hydrocortison und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BB
Corticosteroide, mittelstark wirksam, Kombinationen mit Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BB01
Flumetason und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BB02
Desonid und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BB03
Triamcinolon und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BB04
Hydrocortisonbutyrat und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BC
Corticosteroide, stark wirksam, Kombinationen mit Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BC01
Betamethason und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BC02
Fluocinolonacetonid und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BC03
Fluocortolon und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BC04
Diflucortolon und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07BD
Corticosteroide, sehr stark wirksam, Kombinationen mit Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07C
Corticosteroide, Kombinationen mit Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CA
Corticosteroide, schwach wirksam, Kombinationen mit Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CA01
Hydrocortison und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CA02
Methylprednisolon und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CA03
Prednisolon und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB
Corticosteroide, mittelstark wirksam, Kombinationen mit Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB01
Triamcinolon und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB02
Flupredniden und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB03
Fluorometholon und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB04
Dexamethason und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CB05
Flumetason und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC
Corticosteroide, stark wirksam, Kombinationen mit Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC01
Betamethason und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC02
Fluocinolonacetonid und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC03
Fludroxycortid und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC04
Beclometason und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC05
Fluocinonid und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CC06
Fluocortolon und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CD
Corticosteroide, sehr stark wirksam, Kombinationen mit Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07CD01
Clobetasol und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D07X
Corticosteroide, Andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XA
Corticosteroide, schwach wirksam, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XA01
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XA02
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB
Corticosteroide, mittelstark wirksam, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB01
Flumetason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB02
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB03
Flupredniden
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB04
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB05
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XB30
Kombinationen mittelstark wirksamer Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XC
Corticosteroide, stark wirksam, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XC01
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XC02
Desoximetason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XC03
Mometason
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XC04
Diflucortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D07XD
Corticosteroide, sehr stark wirksam, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08
Antiseptika und Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08A
Antiseptika und Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AA
Acridin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AA01
Ethacridinlactat
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AA02
Aminoacridin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AA03
Euflavin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AB
Aluminium-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC
Biguanide und Amidine
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC01
Dibrompropamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC02
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC03
Propamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC04
Hexamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC05
Polihexanid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AC52
Chlorhexidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AD
Borsäure-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE
Phenol und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE01
Hexachlorophen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE02
Policresulen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE03
Phenol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE04
Triclosan
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE05
Chloroxylenol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AE06
Biphenylol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AF
Nitrofuran-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AF01
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AG
Iod-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AG01
Iodoctylphenoxypolyglycolether
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AG02
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AG03
Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AG04
Diiodhydroxypropan
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AH
Chinolin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AH01
Dequalinium
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AH02
Chlorquinaldol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AH03
Oxichinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AH30
Clioquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ
Quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ01
Benzalkonium
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ02
Cetrimonium
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ03
Cetylpyridinium
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ04
Cetrimid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ05
Benzoxoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ06
Didecyldimethylammoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ57
Octenidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ58
Benzethoniumchlorid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AJ59
Dodecloniumbromid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK
Quecksilber-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK01
Quecksilberamidochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK02
Phenylmercuriborat
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK03
Quecksilberchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK04
Merbromin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK05
Metallisches Quecksilber
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK06
Thiomersal
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AK30
Quecksilberiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AL
Silber-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AL01
Silbernitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AL30
Silber
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX
Andere Antiseptika und Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX01
Wasserstoffperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX02
Eosin
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX03
Propanol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX04
Tosylchloramid-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX05
Isopropanol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX06
Kaliumpermanganat
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX07
Natriumhypochlorit
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX08
Ethanol
WHO Anatomical Therapeutic Chemical classification
0‑L
D08AX53
Propanol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D09
Medizinische Verbände
WHO Anatomical Therapeutic Chemical classification
0‑L
D09A
Medizinische Verbände
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA
Medizinische verbände mit Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA01
Framycetin
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA02
Fusidinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA03
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA04
Phenylquecksilbernitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA05
Benzododecinium
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA06
Triclosan
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA07
Cetylpyridinium
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA08
Aluminiumhydroxychlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA09
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA10
Clioquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA11
Benzalkonium
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA12
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AA13
Iodoform
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AB
Zink-haltige Verbände
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AB01
Zink-haltige Verbände ohne Zusätze
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AB02
Zink-haltige Verbände mit Zusätzen
WHO Anatomical Therapeutic Chemical classification
0‑L
D09AX
Vaselin-haltige Verbände
WHO Anatomical Therapeutic Chemical classification
0‑L
D10
Aknemittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D10A
Aknemittel zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AA
Corticosteroide, Kombinationen zur Behandlung der Akne
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AA01
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AA02
Methylprednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AA03
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AB
Schwefel-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AB01
Bithionol
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AB02
Schwefel
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AB03
Tioxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AB05
Mesulfen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD
Retinoide zur topischen Anwendung bei Akne
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD01
Tretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD02
Retinol
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD03
Adapalen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD04
Isotretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD05
Motretinid
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD51
Tretinoin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD53
Adapalen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AD54
Isotretinoin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AE
Peroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AE01
Benzoylperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AE51
Benzoylperoxid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF
Antiinfektiva zur Behandlung der Akne
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF01
Clindamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF02
Erythromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF03
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF04
Meclocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF51
Clindamycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AF52
Erythromycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX
Andere Aknemittel zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX01
Aluminiumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX02
Resorcin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX03
Azelainsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX04
Aluminiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
D10AX30
Verschiedene Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D10B
Aknemittel zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D10BA
Retinoide zur Behandlung der Akne
WHO Anatomical Therapeutic Chemical classification
0‑L
D10BA01
Isotretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
D10BX
Andere Aknemittel zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D10BX01
Natriumbituminosulfonat
WHO Anatomical Therapeutic Chemical classification
0‑L
D11
Andere Dermatika
WHO Anatomical Therapeutic Chemical classification
0‑L
D11A
Andere Dermatika
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AA
Antihidrotika
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC
Medizinische Haarwaschmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC01
Cetrimid
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC02
Cadmium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC03
Selen-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC06
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC08
Schwefel-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC09
Xenysalat
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AC30
Andere
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AE
Androgene zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AE01
Metandienon
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AF
Warzenmittel und Keratolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AH02
Pimecrolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AH04
Alitretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX
Andere Dermatika
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX01
Minoxidil
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX02
Gamolensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX03
Calciumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX04
Lithiumsuccinat
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX05
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX06
Mequinol
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX08
Tiratricol
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX09
Oxaceprol
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX10
Finasterid
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX11
Hydrochinon
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX12
Pyrithion zink
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX13
Monobenzon
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX14
Tacrolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX15
Pimecrolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX16
Eflornithin
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX17
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX18
Diclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX19
Alitretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX52
Gamolensäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
D11AX57
Kollagen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G
Urogenitalsystem und Sexualhormone
WHO Anatomical Therapeutic Chemical classification
0‑L
G01
Gynäkologische Antiinfektiva und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
G01A
Antiinfektiva und Antiseptika, exkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA01
Nystatin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA02
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA03
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA04
Candicidin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA05
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA06
Hachimycin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA07
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA08
Carfecillin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA09
Mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA10
Clindamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA11
Pentamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AA51
Nystatin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AB
Arsen-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AB01
Acetarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC
Chinolin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC01
Diiodhydroxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC02
Clioquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC03
Chlorquinaldol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC05
Dequalinium
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC06
Broxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AC30
Oxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AD
Organische Säuren
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AD01
Milchsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AD02
Essigsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AD03
Ascorbinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AE
Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AE01
Sulfatolamid
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AE10
Kombinationen von Sulfonamiden
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF
Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF01
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF02
Clotrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF04
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF05
Econazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF06
Ornidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF07
Isoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF08
Tioconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF11
Ketoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF12
Fenticonazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF13
Azanidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF14
Propenidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF15
Butoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF16
Omoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF17
Oxiconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF18
Flutrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AF20
Kombinationen von Imidazol-Derivaten
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AG
Triazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AG02
Terconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX
Andere Antiinfektiva und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX01
Clodantoin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX02
Inosin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX03
Policresulen
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX05
Nifuratel
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX06
Furazolidon
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX09
Methylrosanilin
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX11
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX12
Ciclopirox
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX13
Protiofat
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX14
Lactobacillus-Ferment
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX15
Kupferusnat
WHO Anatomical Therapeutic Chemical classification
0‑L
G01AX66
Octenidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G01B
Antiinfektiva/Antiseptika in Kombination mit Corticosteroiden
WHO Anatomical Therapeutic Chemical classification
0‑L
G01BA
Antibiotika und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
G01BC
Chinolin-Derivate und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
G01BD
Antiseptika und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
G01BE
Sulfonamide und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
G01BF
Imidazol-Derivate und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
G02
Andere Gynäkologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G02A
Wehen fördernde Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AB
Mutterkorn-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AB01
Methylergometrin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AB02
Mutterkorn-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AB03
Ergometrin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AC
Mutterkorn-Alkaloide und Oxytocin inkl. Derivate, in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AC01
Methylergometrin und Oxytocin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD
Prostaglandine
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD01
Dinoprost
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD02
Dinoproston
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD03
Gemeprost
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD04
Carboprost
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD05
Sulproston
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AD06
Misoprostol
WHO Anatomical Therapeutic Chemical classification
0‑L
G02AX
Andere Wehen fördernde Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
G02B
Kontrazeptiva zur lokalen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BA
Intrauterine Kontrazeptiva
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BA01
Plastik-IUP
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BA02
Plastik-IUP mit Kupfer
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BA03
Plastik-IUP mit Progesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BB
Intravaginale Kontrazeptiva
WHO Anatomical Therapeutic Chemical classification
0‑L
G02BB01
Vaginalring mit Gestagenen und Estrogenen
WHO Anatomical Therapeutic Chemical classification
0‑L
G02C
Andere Gynäkologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CA
Sympathomimetika, Wehen hemmend
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CA01
Ritodrin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CA02
Buphenin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CA03
Fenoterol
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB
Prolactinhemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB01
Bromocriptin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB02
Lisurid
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB03
Cabergolin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB04
Quinagolid
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CB05
Metergolin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CC
Antiphlogistika zur vaginalen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CC01
Ibuprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CC02
Naproxen
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CC03
Benzydamin
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CC04
Flunoxaprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CX
Andere Gynäkologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G02CX01
Atosiban
WHO Anatomical Therapeutic Chemical classification
0‑L
G03
Sexualhormone und Modulatoren des Genitalsystems
WHO Anatomical Therapeutic Chemical classification
0‑L
G03A
Hormonelle Kontrazeptiva zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA
Gestagene und Estrogene, fixe Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA01
Etynodiol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA02
Quingestanol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA03
Lynestrenol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA04
Megestrol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA05
Norethisteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA06
Norgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA07
Levonorgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA08
Medroxyprogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA09
Desogestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA10
Gestoden und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA11
Norgestimat und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA12
Drospirenon und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA13
Norelgestromin und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA14
Nomegestrol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AA15
Chlormadinon und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB
Gestagene und Estrogene, Sequenzialpräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB01
Megestrol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB02
Lynestrenol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB03
Levonorgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB04
Norethisteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB05
Desogestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB06
Gestoden und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB07
Chlormadinon und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AB08
dienogest and estradiol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC
Gestagene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC01
Norethisteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC02
Lynestrenol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC03
Levonorgestrel
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC04
Quingestanol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC05
Megestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC06
Medroxyprogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC07
Norgestrienon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC08
Etonogestrel
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AC09
Desogestrel
WHO Anatomical Therapeutic Chemical classification
0‑L
G03AD01
Levonorgestrel
WHO Anatomical Therapeutic Chemical classification
0‑L
G03B
Androgene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BA
3-Oxoandrosten-4-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BA01
Fluoxymesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BA02
Methyltestosteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BA03
Testosteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BB
5-Androstanon-3-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BB01
Mesterolon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03BB02
Androstanolon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03C
Estrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA
Natürliche und halbsynthetische Estrogene, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA01
Ethinylestradiol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA03
Estradiol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA04
Estriol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA06
Chlorotrianisen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA07
Estron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA09
Promestrien
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA53
Estradiol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CA57
Konjugierte Estrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CB
Synthetische Estrogene, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CB01
Dienestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CB02
Diethylstilbestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CB03
Methallenestril
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CB04
Moxestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC
Estrogene, Kombinationen mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC02
Dienestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC03
Methallenestril
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC04
Estron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC05
Diethylstilbestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CC06
Estriol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03CX01
Tibolon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03D
Gestagene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DA
Pregnen-4-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DA01
Gestonoron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DA02
Medroxyprogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DA03
Hydroxyprogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DA04
Progesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB
Pregnadien-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB01
Dydrogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB02
Megestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB03
Medrogeston
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB04
Nomegestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB05
Demegeston
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB06
Chlormadinon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB07
Promegeston
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DB08
Dienogest
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC
Estren-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC01
Allylestrenol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC02
Norethisteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC03
Lynestrenol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC04
Ethisteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC05
Tibolon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC06
Etynodiol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03DC31
Methylestrenolon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03E
Androgene und weibliche Sexualhormone in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EA
Androgene und Estrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EA01
Methyltestosteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EA02
Testosteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EA03
Prasteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EB
Androgen, Gestagen und Estrogen in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EK
Androgene und weibliche Sexualhormone in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
G03EK01
Methyltestosteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03F
Gestagene und Estrogene in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA
Gestagene und Estrogene, fixe Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA01
Norethisteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA02
Hydroxyprogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA03
Ethisteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA04
Progesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA05
Methylnortestosteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA06
Etynodiol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA07
Lynestrenol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA08
Megestrol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA09
Noretynodrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA10
Norgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA11
Levonorgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA12
Medroxyprogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA13
Norgestimat und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA14
Dydrogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA15
Dienogest und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA16
Trimegeston und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FA17
Drospirenon und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB
Gestagene und Estrogene, Sequenzialpräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB01
Norgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB02
Lynestrenol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB03
Chlormadinon und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB04
Megestrol und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB05
Norethisteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB06
Medroxyprogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB07
Medrogeston und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB08
Dydrogesteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB09
Levonorgestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB10
Desogestrel und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03FB11
Trimegeston und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03G
Gonadotropine und andere Ovulationsauslöser
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA
Gonadotropine
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA01
Choriongonadotrophin
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA02
Humanes menopausales Gonadotrophin
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA03
Serumgonadotrophin
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA04
Urofollitropin
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA05
Follitropin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA06
Follitropin beta
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA07
Lutropin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA08
Choriongonadotropin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GA09
Corifollitropin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GB
Ovulationsauslöser, synthetisch
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GB01
Cyclofenil
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GB02
Clomifen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03GB03
Epimestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03H
Antiandrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03HA
Antiandrogene, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
G03HA01
Cyproteron
WHO Anatomical Therapeutic Chemical classification
0‑L
G03HB
Antiandrogene und Estrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03HB01
Cyproteron und Estrogen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03X
Andere Sexualhormone und Modulatoren des Genitalsystems
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XA
Antigonadotropine und ähnliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XA01
Danazol
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XA02
Gestrinon
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XB
Antigestagene
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XB01
Mifepriston
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XC
Selektive Estrogenrezeptor-Modulatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XC01
Raloxifen
WHO Anatomical Therapeutic Chemical classification
0‑L
G03XC02
Bazedoxifen
WHO Anatomical Therapeutic Chemical classification
0‑L
G04
Urologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G04A
Urinary antiseptics and antiinfectives
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AA
Methenamine preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AB
Quinolone derivatives (excl. J01M)
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AC
Nitrofuran derivatives
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AD
Salicylates
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AG
Other urinary antiseptics and antiinfectives
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AH
Sulfonamides in combination with other drugs
WHO Anatomical Therapeutic Chemical classification
0‑L
G04AK
Urinary antiseptics and antiinfectives comb., excl. sulfonamides
WHO Anatomical Therapeutic Chemical classification
0‑L
G04B
Andere Urologika, inkl. Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BA
Harn ansäuernde Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BA01
Ammoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BA03
Calciumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BC
Harnkonkrement lösende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD
Urologische Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD01
Emepronium
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD02
Flavoxat
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD03
Meladrazin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD04
Oxybutynin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD05
Terodilin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD06
Propiverin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD07
Tolterodin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD08
Solifenacin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD09
Trospium
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD10
Darifenacin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BD11
Fesoterodin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE
Mittel bei erektiler Dysfunktion
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE01
Alprostadil
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE02
Papaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE03
Sildenafil
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE04
Yohimbin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE05
Phentolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE06
Moxisylyt
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE07
Apomorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE08
Tadalafil
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE09
Vardenafil
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BE52
Papaverin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BP30
Pflanzliche Urologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX
Andere Urologika
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX01
Magnesiumhydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX03
Acetohydroxamsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX06
Phenazopyridin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX10
Succinimid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX11
Collagen
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX12
Phenylsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX13
Dimethylsulfoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04BX14
Dapoxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04C
Mittel bei Benigner Prostatahyperplasie
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA
Alpha-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA01
Alfuzosin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA02
Tamsulosin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA03
Terazosin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA04
Silodosin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA52
Tamsulosin und Dutasterid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CA53
Tamsulosin und Solifenacin
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CB
Testosteron-5-alfa-Reduktasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CB01
Finasterid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CB02
Dutasterid
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CX
Andere Mittel bei benigner Prostatahyperplasie
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CX01
Pygeum africanum
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CX02
Serenoa repens
WHO Anatomical Therapeutic Chemical classification
0‑L
G04CX03
Mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
H
Systemische Hormonpräparate, exkl. Sexualhormone und Insuline
WHO Anatomical Therapeutic Chemical classification
0‑L
H01
Hypophysen- und Hypothalamushormone und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H01A
Hypophysenvorderlappenhormone und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AA
ACTH
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AA01
Corticotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AA02
Tetracosactid
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AB
Thyrotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AB01
Thyrotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AC
Somatropin und Somatropin-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AC01
Somatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AC02
Somatrem
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AC03
Mecasermin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AC04
Sermorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AX
Andere Hypophysenvorderlappenhormone und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H01AX01
Pegvisomant
WHO Anatomical Therapeutic Chemical classification
0‑L
H01B
Hypophysenhinterlappenhormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA
Vasopressin und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA01
Vasopressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA02
Desmopressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA03
Lypressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA04
Terlipressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA05
Ornipressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BA06
Argipressin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BB
Oxytocin und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BB01
Demoxytocin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BB02
Oxytocin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01BB03
Carbetocin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01C
Hypothalamushormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CA
Gonadotropin-Releasing-Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CA01
Gonadorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CA02
Nafarelin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CA03
Histrelin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CA93
Gonadotrophin-releasing hormones
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CB
Anti-Wachstumshormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CB01
Somatostatin
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CB02
Octreotid
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CB03
Lanreotid
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CC
Gonadotropin-Releasing-Hormon-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CC01
Ganirelix
WHO Anatomical Therapeutic Chemical classification
0‑L
H01CC02
Cetrorelix
WHO Anatomical Therapeutic Chemical classification
0‑L
H02
Corticosteroide zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
H02A
Corticosteroide zur systemischen Anwendung, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AA
Mineralocorticoide
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AA01
Aldosteron
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AA02
Fludrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AA03
Desoxycorton
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB
Glucocorticoide
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB01
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB02
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB03
Fluocortolon
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB04
Methylprednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB05
Paramethason
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB06
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB07
Prednison
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB08
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB09
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB10
Cortison
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB11
Prednyliden
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB12
Rimexolon
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB13
Deflazacort
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB14
Cloprednol
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB15
Meprednison
WHO Anatomical Therapeutic Chemical classification
0‑L
H02AB17
Cortivazol
WHO Anatomical Therapeutic Chemical classification
0‑L
H02B
Corticosteroide zur systemischen Anwendung, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
H02BX
Corticosteroide zur systemischen Anwendung, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
H02BX01
Methylprednisolon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
H02C
Nebennierenhemmstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
H02CA
Anticorticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
H02CA01
Trilostan
WHO Anatomical Therapeutic Chemical classification
0‑L
H03
Schilddrüsentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
H03A
Schilddrüsenpräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA
Schilddrüsenhormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA01
Levothyroxin-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA02
Liothyronin-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA03
Kombinationen von Levothyroxin und Liothyronin
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA04
Tiratricol
WHO Anatomical Therapeutic Chemical classification
0‑L
H03AA05
Zubereitungen aus Schilddrüsengewebe
WHO Anatomical Therapeutic Chemical classification
0‑L
H03B
Thyreostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BA
Thiouracile
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BA01
Methylthiouracil
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BA02
Propylthiouracil
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BA03
Benzylthiouracil
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BB
Schwefel-haltige Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BB01
Carbimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BB02
Thiamazol
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BB52
Thiamazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BC
Perchlorate
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BC01
Kaliumperchlorat
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BX
Andere Thyreostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BX01
Diiodtyrosin
WHO Anatomical Therapeutic Chemical classification
0‑L
H03BX02
Dibromtyrosin
WHO Anatomical Therapeutic Chemical classification
0‑L
H03C
Iodtherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
H03CA
Iodtherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
H04
Pankreashormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H04A
Glykogenolytische Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H04AA
Glykogenolytische Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
H04AA01
Glucagon
WHO Anatomical Therapeutic Chemical classification
0‑L
H05
Calciumhomöostase
WHO Anatomical Therapeutic Chemical classification
0‑L
H05A
Nebenschilddrüsenhormone und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H05AA
Nebenschilddrüsenhormone und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
H05AA01
Nebenschilddrüsenextrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
H05AA02
Teriparatid
WHO Anatomical Therapeutic Chemical classification
0‑L
H05AA03
Parathyroid Hormon
WHO Anatomical Therapeutic Chemical classification
0‑L
H05B
Nebenschilddrüsen-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BA
Calcitonin-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BA01
Calcitonin (Lachs, synthetisch)
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BA02
Calcitonin (Schwein, natürlich)
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BA03
Calcitonin (Mensch, synthetisch)
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BA04
Elcatonin
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BX
Andere Nebenschilddrüsen-antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BX01
Cinacalcet
WHO Anatomical Therapeutic Chemical classification
0‑L
H05BX02
Paricalcitol
WHO Anatomical Therapeutic Chemical classification
0‑L
I07AA
inactivated viral vaccines
WHO Anatomical Therapeutic Chemical classification
0‑L
I07AA06
Canine Herpesvirus vaccine
WHO Anatomical Therapeutic Chemical classification
0‑L
I09AA07
Inactivated Porcine Circovirus vaccine
WHO Anatomical Therapeutic Chemical classification
0‑L
J
Antiinfektiva zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J01
Antibiotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J01A
Tetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA
Tetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA01
Demeclocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA02
Doxycyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA03
Chlortetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA04
Lymecyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA05
Metacyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA06
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA07
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA08
Minocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA09
Rolitetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA10
Penimepicyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA11
Clomocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA12
Tigecyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA20
Kombinationen von Tetracyclinen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01AA56
Oxytetracyclin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01B
Amphenicole
WHO Anatomical Therapeutic Chemical classification
0‑L
J01BA
Amphenicole
WHO Anatomical Therapeutic Chemical classification
0‑L
J01BA01
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01BA02
Thiamphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01BA52
Thiamphenicol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01C
Betalactam-Antibiotika, Penicilline
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA
Penicilline mit erweitertem Wirkungsspektrum
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA01
Ampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA02
Pivampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA03
Carbenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA04
Amoxicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA05
Carindacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA06
Bacampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA07
Epicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA08
Pivmecillinam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA09
Azlocillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA10
Mezlocillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA11
Mecillinam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA12
Piperacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA13
Ticarcillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA14
Metampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA15
Talampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA16
Sulbenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA17
Temocillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA18
Hetacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CA51
Ampicillin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE
Beta-Lactamase-sensitive Penicilline
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE01
Benzylpenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE02
Phenoxymethylpenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE03
Propicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE04
Azidocillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE05
Pheneticillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE06
Penamecillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE07
Clometocillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE08
Benzylpenicillin-Benzathin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE09
Benzylpenicillin-procain
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE10
Phenoxymethylpenicillin-Benzathin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CE30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF
Beta-Lactamase-resistente Penicilline
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF01
Dicloxacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF02
Cloxacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF03
Meticillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF04
Oxacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CF05
Flucloxacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CG
Beta-Lactamase-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CG01
Sulbactam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CG02
Tazobactam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR
Kombinationen von Penicillinen, inkl. Beta-Lactamase-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR01
Ampicillin und Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR02
Amoxicillin und Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR03
Ticarcillin und Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR04
Sultamicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR05
Piperacillin und Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01CR50
Kombinationen von Penicillinen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01D
Andere Beta-Lactam-Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DA
Cephalosporins and related substances *
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB
Cephalosporine der 1. Generation
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB01
Cefalexin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB02
Cefaloridin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB03
Cefalotin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB04
Cefazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB05
Cefadroxil
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB06
Cefazedon
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB07
Cefatrizin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB08
Cefapirin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB09
Cefradin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB10
Cefacetril
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB11
Cefroxadin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DB12
Ceftezol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC
Cephalosporine der 2. Generation
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC01
Cefoxitin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC02
Cefuroxim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC03
Cefamandol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC04
Cefaclor
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC05
Cefotetan
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC06
Cefonicid
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC07
Cefotiam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC08
Loracarbef
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC09
Cefmetazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC10
Cefprozil
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DC11
Ceforanid
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD
Cephalosporine der 3. Generation
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD01
Cefotaxim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD02
Ceftazidim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD03
Cefsulodin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD04
Ceftriaxon
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD05
Cefmenoxim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD06
Latamoxef
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD07
Ceftizoxim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD08
Cefixim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD09
Cefodizim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD10
Cefetamet
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD11
Cefpiramid
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD12
Cefoperazon
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD13
Cefpodoxim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD14
Ceftibuten
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD15
Cefdinir
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD16
Cefditoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD54
Ceftriaxon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD62
Cefoperazon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DD91
Cefovecin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DE
Cephalosporine der 4. Generation
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DE01
Cefepim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DE02
Cefpirom
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DF
Monobactame
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DF01
Aztreonam
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DH
Carbapeneme
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DH02
Meropenem
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DH03
Ertapenem
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DH04
Doripenem
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DH51
Imipenem und Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
J01DI02
Ceftarolin fosamil
WHO Anatomical Therapeutic Chemical classification
0‑L
J01E
Sulfonamide und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EA
Trimethoprim und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EA01
Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EA02
Brodimoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB
Kurz wirkende Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB01
Sulfaisodimidin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB02
Sulfamethizol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB03
Sulfadimidin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB04
Sulfapyridin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB05
Sulfafurazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB06
Sulfanilamid
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB07
Sulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB08
Sulfathiourea
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EB20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EC
Mittellang wirkende Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EC01
Sulfamethoxazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EC02
Sulfadiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EC03
Sulfamoxol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EC20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED
Lang wirkende Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED01
Sulfadimethoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED02
Sulfalen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED03
Sulfametomidin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED04
Sulfametoxydiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED05
Sulfamethoxypyridazin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED06
Sulfaperin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED07
Sulfamerazin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED08
Sulfaphenazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED09
Sulfamazon
WHO Anatomical Therapeutic Chemical classification
0‑L
J01ED20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE
Kombinationen von Sulfonamiden und Trimethoprim, inkl. Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE01
Sulfamethoxazol und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE02
Sulfadiazin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE03
Sulfametrol und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE04
Sulfamoxol und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE05
Sulfadimidin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE06
Sulfadiazin und Tetroxoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01EE07
Sulfamerazin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
J01F
Makrolide, Lincosamide und Streptogramine
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA
Makrolide
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA01
Erythromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA02
Spiramycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA03
Midecamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA05
Oleandomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA06
Roxithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA07
Josamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA08
Troleandomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA09
Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA10
Azithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA11
Miocamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA12
Rokitamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA13
Dirithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA14
Flurithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA15
Telithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FA95
Gamithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FF
Lincosamide
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FF01
Clindamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FF02
Lincomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FG
Streptogramine
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FG01
Pristinamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01FG02
Quinupristin/Dalfopristin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01G
Aminoglykosid-Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GA
Streptomycine
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GA01
Streptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GA02
Streptoduocin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB
Andere Aminoglykoside
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB01
Tobramycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB03
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB04
Kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB05
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB06
Amikacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB07
Netilmicin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB08
Sisomicin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB09
Dibekacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB10
Ribostamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01GB11
Isepamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01M
Chinolone
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA
Fluorchinolone
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA01
Ofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA02
Ciprofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA03
Pefloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA04
Enoxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA05
Temafloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA06
Norfloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA07
Lomefloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA08
Fleroxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA09
Sparfloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA10
Rufloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA11
Grepafloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA12
Levofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA13
Trovafloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA14
Moxifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA15
Gemifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA16
Gatifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA17
Prulifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA18
Pazufloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MA19
Garenoxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB
Andere Chinolone
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB01
Rosoxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB02
Nalidixinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB03
Piromidsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB04
Pipemidsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB05
Oxolinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB06
Cinoxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01MB07
Flumequin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01R
Kombinationen von Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01RA
Kombinationen von Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01RA01
Penicilline, Kombination mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01RA02
Sulfonamide, Kombination mit anderen Antibiotika (exkl. Trimethoprim)
WHO Anatomical Therapeutic Chemical classification
0‑L
J01RA03
Cefuroxim, Kombination mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01RA04
Spiramycin, Kombination mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01X
Andere Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XA
Glycopeptid-Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XA01
Vancomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XA02
Teicoplanin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XB
Polymyxine
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XB01
Colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XB02
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XC
Steroid-Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XC01
Fusidinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XD
Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XD01
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XD02
Tinidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XD03
Ornidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XE
Nitrofuran-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XE01
Nitrofurantoin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XE02
Nifurtoinol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX
Andere Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX01
Fosfomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX02
Xibornol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX03
Clofoctol
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX04
Spectinomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX05
Methenamin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX06
Mandelsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX07
Nitroxolin
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX08
Linezolid
WHO Anatomical Therapeutic Chemical classification
0‑L
J01XX09
Daptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J02
Antimykotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J02A
Antimykotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AA01
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AA02
Hachimycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AB
Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AB01
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AB02
Ketoconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AC
Triazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AC01
Fluconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AC02
Itraconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AC03
Voriconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AC04
Posaconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AX
Andere Antimykotika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AX01
Flucytosin
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AX04
Caspofungin
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AX05
Micafungin
WHO Anatomical Therapeutic Chemical classification
0‑L
J02AX06
Anidulafungin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04
Mittel gegen Mykobakterien
WHO Anatomical Therapeutic Chemical classification
0‑L
J04A
Mittel zur Behandlung der Tuberkulose
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AA
Aminosalicylsäure und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AA01
Aminosalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AA02
Natriumaminosalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AA03
Calciumaminosalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB01
Cycloserin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB02
Rifampicin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB03
Rifamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB04
Rifabutin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB05
Rifapentin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AB30
Capreomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AC
Hydrazide
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AC01
Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AC51
Isoniazid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AD
Thiocarbamid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AD01
Protionamid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AD02
Tiocarlid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AD03
Ethionamid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AK
Andere Mittel zur Behandlung der Tuberkulose
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AK01
Pyrazinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AK02
Ethambutol
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AK03
Terizidon
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AK04
Morinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM
Kombinationen von Mitteln zur Behandlung der Tuberkulose
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM01
Streptomycin und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM02
Rifampicin und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM03
Ethambutol und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM04
Thioacetazon und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM05
Rifampicin, Pyrazinamid und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04AM06
Rifampicin, Pyrazinamid, Ethambutol und Isoniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
J04B
Mittel zur Behandlung der Lepra
WHO Anatomical Therapeutic Chemical classification
0‑L
J04BA
Mittel zur Behandlung der Lepra
WHO Anatomical Therapeutic Chemical classification
0‑L
J04BA01
Clofazimin
WHO Anatomical Therapeutic Chemical classification
0‑L
J04BA02
Dapson
WHO Anatomical Therapeutic Chemical classification
0‑L
J04BA03
Aldesulfonnatrium
WHO Anatomical Therapeutic Chemical classification
0‑L
J05
Antivirale Mittel zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J05A
Direkt wirkende antivirale Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AA
Thiosemicarbazone
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AA01
Metisazon
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB
Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB01
Aciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB02
Idoxuridin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB03
Vidarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB04
Ribavirin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB06
Ganciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB09
Famciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB11
Valaciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB12
Cidofovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB13
Penciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB14
Valganciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AB15
Brivudin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AC
Cyclische Amine
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AC02
Rimantadin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AC03
Tromantadin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AD
Phosphonsäure-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AD01
Foscarnet
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AD02
Fosfonet
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE
Proteasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE01
Saquinavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE02
Indinavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE03
Ritonavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE04
Nelfinavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE05
Amprenavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE06
Lopinavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE07
Fosamprenavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE08
Atazanavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE09
Tipranavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AE10
Darunavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF
Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF01
Zidovudin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF02
Didanosin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF03
Zalcitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF04
Stavudin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF05
Lamivudin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF06
Abacavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF07
Tenofovir Disoproxil
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF08
Adefovir dipivoxil
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF09
Emtricitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF10
Entecavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AF11
Telbivudine
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AG
Nicht-Nukleosidale Inhibitoren der Reverse-Transkriptase
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AG01
Nevirapin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AG02
Delavirdin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AG03
Efavirenz
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AG04
Etravirin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AH
Neuraminidasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AH01
Zanamivir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AH02
Oseltamivir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR
Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR01
Ziduvudin und Lamivudin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR02
Lamivudin und Abacavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR03
Tenofovir disoproxil und Emtricitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR04
Zidovudin, Lamivudin und Abacavir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR05
Zidovudin, Lamivudin und Nevirapin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AR06
Emtricitabin, Tenofovir disoproxil und Efavirenz
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX
Andere antivirale Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX01
Moroxydin
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX02
Lysozym
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX05
Inosin-Pranobex
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX06
Pleconaril
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX07
Enfuvirtid
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX08
Raltegravir
WHO Anatomical Therapeutic Chemical classification
0‑L
J05AX09
Maraviroc
WHO Anatomical Therapeutic Chemical classification
0‑L
J06
Immunsera und Immunglobuline
WHO Anatomical Therapeutic Chemical classification
0‑L
J06A
Immunsera
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA
Immunsera
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA01
Diphtherie-Antitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA02
Tetanus-Antitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA03
Schlangengift-Antiserum
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA04
Botulinum-Antitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA05
Gasbrand-Serum
WHO Anatomical Therapeutic Chemical classification
0‑L
J06AA06
Tollwut-Serum
WHO Anatomical Therapeutic Chemical classification
0‑L
J06B
Immunglobuline
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BA
Immunglobuline, normal human
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BA01
Immunglobuline, normal human, zur extravasalen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BA02
Immunglobuline, normal human, zur intravasalen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB
Spezifische Immunglobuline
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB01
Anti-D(rh)-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB02
Tetanus-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB03
Varicella/Zoster-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB04
Hepatitis B-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB05
Tollwut-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB06
Röteln-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB07
Kuhpocken-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB08
Staphylococcus-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB09
Cytomegalievirus-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB10
Diphtherie-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB11
Hepatitis-A-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB12
FSME-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB13
Pertussis-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB14
Masern-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB15
Mumps-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB16
Palivizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BB30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BC
Andere Immunglobuline
WHO Anatomical Therapeutic Chemical classification
0‑L
J06BC01
Nebacumab
WHO Anatomical Therapeutic Chemical classification
0‑L
J07
Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07A
Bakterielle Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AC
Milzbrand-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AC01
Anthrax-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AD
Brucellose-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AD01
Brucella-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AE
Cholera-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AE01
Cholera, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AE02
Cholera, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AE51
Cholera, Kombinationen mit Typhus-Impfstoff, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AF
Diphtherie-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AF01
Diphtherie-Toxoid
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AG
Haemophilus-influenza-B-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AG01
Haemophilus-influenzae B, gereinigtes Antigen konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AG51
Haemophilus-influenzae B, Kombinationen mit Toxoiden
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AG52
Haemophilus-influenzae B, Kombinationen mit Pertussis und Toxoiden
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AG53
Haemophilus-influenzae B, Kombinationen mit Meningokokkus C, konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH
Meningokokken-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH01
Meningokokkus A, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH02
Andere Meningokokken monovalent, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH03
Meningokokkus bivalent, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH04
Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH05
Andere Meningokokken polyvalent, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH06
Meningokokkus B, Äußeres-Membranvesikel-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH07
Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AH08
Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AJ
Pertussis-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AJ01
Pertussis, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AJ02
Pertussis, gereinigtes Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AJ51
Pertussis, inaktiviert, ganze Zelle, Kombinationen mit Toxoiden
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AJ52
Pertussis, gereinigtes Antigen, Kombinationen mit Toxoiden
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AK
Pest-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AK01
Pest, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AL
Pneumokokken-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AL01
Pneumokokken, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AL02
Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AM
Tetanus-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AM01
Tetanus-Toxoid
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AM51
Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AM52
Tetanus-Toxoid, Kombinationen mit Tetanus-Immunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AN
Tuberkulose-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AN01
Tuberkulose, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AP
Typhus-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AP01
Typhus, oral, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AP02
Typhus, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AP03
Typhus, gereinigtes Polysaccharid-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AP10
Typhus, Kombinationen mit Paratyphustypen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AR
Typhus (exanthematicus)-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AR01
Typhus exanthematicus, inaktiviert, ganze Zelle
WHO Anatomical Therapeutic Chemical classification
0‑L
J07AX
Andere bakterielle Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07B
Virale Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BA
Encephalitis-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BA01
FSME, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BA02
Encephalitis, japanische, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BB
Influenza-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BB01
Influenza, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BB02
Influenza, gereinigtes Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BC
Hepatitis-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BC01
Hepatitis B, gereinigtes Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BC02
Hepatitis A, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BC20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD
Masern-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD01
Masern, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD51
Masern, Kombinationen mit Mumps, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD52
Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD53
Masern, Kombinationen mit Röteln, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BD54
Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BE
Mumps-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BE01
Mumps, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BF
Poliomyelitis-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BF01
Poliomyelitis, oral, monovalent, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BF02
Poliomyelitis, oral, trivalent, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BF03
Poliomyelitis, trivalent, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BG
Tollwut-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BG01
Tollwut, inaktiviert, ganzes Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BH
Rotavirus-Diarrhoe-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BH01
Rotavirus, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BH02
Rotavirus, pentavalent, lebend, Reassortanten
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BJ
Röteln-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BJ01
Röteln, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BJ51
Röteln, Kombinationen mit Mumps, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BK
Varicella Zoster Impfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BK01
Varicella, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BK02
Zoster Virus lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BL
Gelbfieber-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BL01
Gelbfieber, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BM
Papillomvirus-Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BM01
Humaner Papillomvirus-Impfstoff (Typen 6,11,16,18)
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BM02
Humaner Papillomvirus-Impfstoff (Typen 16,18)
WHO Anatomical Therapeutic Chemical classification
0‑L
J07BX
Varicella, lebend abgeschwächt
WHO Anatomical Therapeutic Chemical classification
0‑L
J07C
Bakterielle und virale Impfstoffe, kombiniert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA
Bakterielle und virale Impfstoffe, kombiniert
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA01
Diphtherie-Poliomyelitis-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA02
Diphtherie-Pertussis-Poliomyelitis-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA03
Diphtherie-Röteln-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA04
Haemophilus-influenzae B und Poliomyelitis
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA05
Diphtherie-Hepatitis B-Pertussis-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA06
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA07
Diphtherie-Hepatitis B-Tetanus
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA08
Hämophilus influenzae B und Hepatitis B
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA09
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA10
Typhus-Hepatitis A
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA11
Diphtherie-Haemophilus-influenzae B-Pertussis-Tetanus-Hepatitis B
WHO Anatomical Therapeutic Chemical classification
0‑L
J07CA12
Diphtherie-Pertussis-Poliomyelitis-Tetanus-Hepatitis B
WHO Anatomical Therapeutic Chemical classification
0‑L
J07X
Andere Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
J51DB90
Cefalonium
WHO Anatomical Therapeutic Chemical classification
0‑L
L
Antineoplastische und Immunmodulierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01
Antineoplastische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01A
Alkylierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA
Stickstofflost-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA01
Cyclophosphamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA02
Chlorambucil
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA03
Melphalan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA05
Chlormethin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA06
Ifosfamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA07
Trofosfamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA08
Prednimustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AA09
Bendamustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AB
Alkylsulfonate
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AB01
Busulfan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AB02
Treosulfan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AB03
Mannosulfan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AC
Ethylenimine
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AC01
Thiotepa
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AC02
Triaziquon
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AC03
Carboquon
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD
Nitrosoharnstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD01
Carmustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD02
Lomustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD03
Semustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD04
Streptozocin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD05
Fotemustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD06
Nimustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AD07
Ranimustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AG
Epoxide
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AG01
Etoglucid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AX
Andere alkylierende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AX01
Mitobronitol
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AX02
Pipobroman
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AX03
Temozolomid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01AX04
Dacarbazin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01B
Antimetabolite
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BA
Folsäure-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BA01
Methotrexat
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BA03
Raltitrexed
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BA04
Pemetrexed
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB
Purin-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB02
Mercaptopurin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB03
Tioguanin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB04
Cladribin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB05
Fludarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB06
Clofarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BB07
Nelarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC
Pyrimidin-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC01
Cytarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC02
Fluorouracil
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC03
Tegafur
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC04
Carmofur
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC05
Gemcitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC06
Capecitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC08
Decitabin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC52
Fluorouracil, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
L01BC53
Tegafur, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
L01C
Pflanzliche Alkaloide und andere Natürliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CA
Vinka-Alkaloide und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CA01
Vinblastin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CA02
Vincristin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CA03
Vindesin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CA04
Vinorelbin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CB
Podophyllotoxin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CB01
Etoposid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CB02
Teniposid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CC
Colchicin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CC01
Demecolcin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CD
Taxane
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CD01
Paclitaxel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CD02
Docetaxel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CX
Andere pflanzliche Alkaloide und natürliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01CX01
Trabectedin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01D
Zytotoxische Antibiotika und verwandte Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DA
Actinomycine
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DA01
Dactinomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB
Anthracycline und verwandte Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB01
Doxorubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB02
Daunorubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB03
Epirubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB04
Aclarubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB05
Zorubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB06
Idarubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB07
Mitoxantron
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB08
Pirarubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB09
Valrubicin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DB11
Pixantron
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DC
Andere zytotoxische Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DC01
Bleomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DC02
Plicamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01DC03
Mitomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01X
Andere antineoplastische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XA
Platin-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XA01
Cisplatin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XA02
Carboplatin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XA03
Oxaliplatin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XB
Methylhydrazine
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XB01
Procarbazin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC
Monoklonale Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC01
Edrecolomab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC02
Rituximab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC03
Trastuzumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC04
Alemtuzumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC05
Gemtuzumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC06
Cetuximab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC07
Bevacizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC08
Panitumumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC09
Catumaxomab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC10
Ofatumumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XC11
Ipilimumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD
Sensibilisatoren für die photodynamische/Radio- Therapie
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD01
Porfimer natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD03
Methylaminolevulinat
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD04
Aminolevulin-Säure
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD05
Temoporfin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XD06
Efaproxiral
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE
Proteinkinase Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE01
Imatinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE02
Gefitinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE03
Erlotinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE04
Sunitinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE05
Sorafenib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE06
Dasatinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE07
Lapatinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE08
Nilotinib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE09
Temsirolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XE11
Pazopanib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX
Andere antineoplastische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX01
Amsacrin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX02
Asparaginase
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX03
Altretamin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX05
Hydroxycarbamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX07
Lonidamin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX08
Pentostatin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX09
Miltefosin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX10
Masoprocol
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX11
Estramustin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX14
Tretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX16
Mitoguazon
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX17
Topotecan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX18
Tiazofurin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX19
Irinotecan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX22
Alitretinoin
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX23
Mitotan
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX24
Pegaspargase
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX25
Bexaroten
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX27
Arsentrioxid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX29
Denileukin diftitox
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX32
Bortezomib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX33
Celecoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XX35
Anagrelid
WHO Anatomical Therapeutic Chemical classification
0‑L
L01XY
Kombinationen von antineoplastischen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
L02
Endokrine Therapie
WHO Anatomical Therapeutic Chemical classification
0‑L
L02A
Hormone und verwandte Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AA
Estrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AA01
Diethylstilbestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AA02
Polyestradiolphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AA03
Ethinylestradiol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AA04
Fosfestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AB
Gestagene
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AB01
Megestrol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AB02
Medroxyprogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AB03
Gestonoron
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AE
Gonadotropin-Releasing-Hormon-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AE01
Buserelin
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AE02
Leuprorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AE03
Goserelin
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AE04
Triptorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
L02AX
Andere Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
L02B
Hormonantagonisten und verwandte Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BA
Antiestrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BA01
Tamoxifen
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BA02
Toremifen
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BA03
Fulvestrant
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BB
Antiandrogene
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BB01
Flutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BB02
Nilutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BB03
Bicalutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG
Enzym-Inhibitoren
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG01
Aminoglutethimid
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG02
Formestan
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG03
Anastrozol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG04
Letrozol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG05
Vorozol
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BG06
Exemestan
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BX
Andere Hormonantagonisten und verwandte Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BX01
Abarelix
WHO Anatomical Therapeutic Chemical classification
0‑L
L02BX02
Degarelix
WHO Anatomical Therapeutic Chemical classification
0‑L
L03
Immunstimulanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
L03A
Zytokine und Immunmodulatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA
Koloniestimulierende Faktoren
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA02
Filgrastim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA03
Molgramostim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA09
Sargramostim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA10
Lenograstim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA12
Ancestim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AA13
Pegfilgrastim
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB
Interferone
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB01
Interferon-alfa, natürlich
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB02
Interferon-beta, natürlich
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB03
Interferon-gamma
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB04
Interferon-alfa-2a
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB05
Interferon-alfa-2b
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB06
Interferon-alfa-n1
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB07
Interferon-beta-1a
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB08
Interferon-beta-1b
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB09
Interferon alfacon-1
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB10
Peginterferon alfa-2b
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB11
Peginterferon alfa-2a
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AB60
Peginterferon alfa-2b, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AC
Interleukine
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AC01
Aldesleukin
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AC02
Oprelvekin
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX
Andere Zytokine und Immunmodulatoren
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX01
Lentinan
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX02
Roquinimex
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX03
BCG-Impfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX04
Pegademase
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX05
Pidotimod
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX07
Poly I:C
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX08
Poly ICLC
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX09
Thymopentin
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX10
Immunocyanin
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX11
Tasonermin
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX12
Melanom-Impfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX13
Glatirameracetat
WHO Anatomical Therapeutic Chemical classification
0‑L
L03AX14
Histamin dihydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
L04
Immunsuppressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
L04A
Immunsuppressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA
Selektive Immunsuppressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA01
Ciclosporin
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA02
Muromonab-CD3
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA03
Antilymphocytäres Immunglobulin (Pferd)
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA04
Antithymocytäres Immunglobulin (Kaninchen)
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA05
Tacrolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA06
Mycophenolsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA08
Daclizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA09
Basiliximab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA10
Sirolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA11
Etanercept
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA12
Infliximab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA13
Leflunomid
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA14
Anakinra
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA15
Alefacept
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA16
Afelimomab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA17
Adalimumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA18
Everolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA19
Gusperimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA21
Efalizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA22
Abetimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA23
Natalizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA24
Abatacept
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA25
Eculizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA26
Belimumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AA28
Belatacept
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AB02
Infliximab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AC03
Anakinra
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AC05
Ustekinumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AC07
Tocilizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AD01
Ciclosporin
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AD02
Tacrolimus
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX
Andere Immunsuppressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX01
Azathioprin
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX02
Thalidomid
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX03
Methotrexat
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX04
Lenalidomid
WHO Anatomical Therapeutic Chemical classification
0‑L
L04AX05
Pirfenidon
WHO Anatomical Therapeutic Chemical classification
0‑L
M
Muskel- und Skelettsystem
WHO Anatomical Therapeutic Chemical classification
0‑L
M01
Antiphlogistika und Antirheumatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M01A
Nichtsteroidale antiphlogistika und Antirheumatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA
Butylpyrazolidine
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA01
Phenylbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA02
Mofebutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA03
Oxyphenbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA05
Clofezon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AA06
Kebuzon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB
Essigsäure-Derivate und verwandte Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB01
Indometacin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB02
Sulindac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB03
Tolmetin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB04
Zomepirac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB05
Diclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB06
Alclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB07
Bumadizon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB08
Etodolac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB09
Lonazolac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB10
Fentiazac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB11
Acemetacin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB12
Difenpiramid
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB13
Oxametacin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB14
Proglumetacin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB15
Ketorolac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB16
Aceclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB17
Bufexamac
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB51
Indometacin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AB55
Diclofenac, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC
Oxicame
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC01
Piroxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC02
Tenoxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC04
Droxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC05
Lornoxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AC06
Meloxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE
Propionsäure-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE01
Ibuprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE02
Naproxen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE03
Ketoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE04
Fenoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE05
Fenbufen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE06
Benoxaprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE07
Suprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE08
Pirprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE09
Flurbiprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE10
Indoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE11
Tiaprofensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE12
Oxaprozin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE13
Ibuproxam
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE14
Dexibuprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE15
Flunoxaprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE16
Alminoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE17
Dexketoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE51
Ibuprofen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE52
Naproxen und Esomeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AE53
Ketoprofen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AG
Fenamate
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AG01
Mefenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AG02
Tolfenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AG03
Flufenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AG04
Meclofenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH
Coxibe
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH01
Celecoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH02
Rofecoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH03
Valdecoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH04
Parecoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH05
Etoricoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AH06
Lumiracoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX
Andere nichtsteroidale Antiphlogistika und Antirheumatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX01
Nabumeton
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX02
Nifluminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX04
Azapropazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX05
Glukosamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX07
Benzydamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX12
Glukosaminoglycanpolysulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX13
Proquazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX14
Orgotein
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX17
Nimesulid
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX18
Feprazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX21
Diacerein
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX22
Morniflumat
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX23
Tenidap
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX24
Oxaceprol
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX25
Chondroitinsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
M01AX68
Feprazon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01B
Antiphlogistika/Antirheumatika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
M01BA
Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden
WHO Anatomical Therapeutic Chemical classification
0‑L
M01BA01
Phenylbutazon und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
M01BA02
Dipyrocetyl und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
M01BA03
Acetylsalicylsäure und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
M01BX
Andere Antiphlogistika/Antirheumatika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
M01C
Spezifische Antirheumatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CA
Chinoline
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CA03
Oxycinchophen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB
Gold-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB01
Natriumaurothiomalat
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB02
Natrium aurothiosulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB03
Auranofin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB04
Aurothioglucose
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CB05
Aurotioprol
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CC
Penicillamin und ähnliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CC01
Penicillamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CC02
Bucillamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M01CX
Andere spezifische Antirheumatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M02
Topische Mittel gegen Gelenk- und Muskelschmerzen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02A
Topische Mittel gegen Gelenk- und Muskelschmerzen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA
Nichtsteroidale Antiphlogistika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA01
Phenylbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA02
Mofebutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA03
Clofezon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA04
Oxyphenbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA05
Benzydamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA06
Etofenamat
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA07
Piroxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA08
Felbinac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA09
Bufexamac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA10
Ketoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA11
Bendazac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA12
Naproxen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA13
Ibuprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA14
Fentiazac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA15
Diclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA16
Feprazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA17
Nifluminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA18
Meclofenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA19
Flurbiprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA21
Tolmetin
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA22
Suxibuzon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA23
Indometacin
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA24
Nifenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AA25
Aceclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AB
Capsicum-haltige Zubereitungen und ähnliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AC
Zubereitungen mit Salicylsäure-Derivaten
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AX
Andere topische Mittel gegen Gelenk- und Muskelschmerzen
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AX02
Tolazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AX03
Dimethylsulfoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
M02AX10
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
M03
Muskelrelaxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
M03A
Muskelrelaxanzien, peripher wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AA
Curare-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AA01
Alcuronium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AA02
Tubocurarin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AA04
Dimethyltubocurarin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AB
Cholin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AB01
Suxamethonium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC
Andere quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC01
Pancuronium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC02
Gallamin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC03
Vecuronium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC04
Atracurium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC05
Hexafluronium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC06
Pipecuroniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC07
Doxacuriumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC08
Fazadiniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC09
Rocuroniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC10
Mivacuriumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AC11
Cisatracurium
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AX
Andere Muskelrelaxanzien, peripher wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M03AX01
Botulinumtoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03B
Muskelrelaxanzien, zentral wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA
Carbaminsäureester
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA01
Phenprobamat
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA02
Carisoprodol
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA03
Methocarbamol
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA04
Styramat
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA05
Febarbamat
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA51
Phenprobamat, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA52
Carisoprodol, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA53
Methocarbamol, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA71
Phenprobamat, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA72
Carisoprodol, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BA73
Methocarbamol, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB
Oxazol-, Thiazin- und Triazin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB02
Chlormezanon
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB03
Chlorzoxazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB52
Chlormezanon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB53
Chlorzoxazon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB72
Chlormezanon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BB73
Chlorzoxazon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BC
Ether, chemisch den Antihistaminika verwandt
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BC01
Orphenadrin (citrat)
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BC51
Orphenadrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX
Andere zentral wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX01
Baclofen
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX02
Tizanidin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX03
Pridinol
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX04
Tolperison
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX05
Thiocolchicosid
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX06
Mephenesin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX07
Tetrazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX08
Cyclobenzaprin
WHO Anatomical Therapeutic Chemical classification
0‑L
M03BX30
Fenyramidol
WHO Anatomical Therapeutic Chemical classification
0‑L
M03C
Muskelrelaxanzien, direkt wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M03CA
Dantrolen und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
M03CA01
Dantrolen
WHO Anatomical Therapeutic Chemical classification
0‑L
M04
Gichtmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M04A
Gichtmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AA
Urikostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AA01
Allopurinol
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AA02
Tisopurin
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AA03
Febuxostat
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AA51
Allopurinol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AB
Urikosurika
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AB01
Probenecid
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AB02
Sulfinpyrazon
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AB03
Benzbromaron
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AB04
Isobromindion
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AC
Gichtmittel ohne Effekt auf den Harnsäuremetabolismus
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AC01
Colchicin
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AC02
Cinchophen
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AX
Andere Gichtmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
M04AX01
Uratoxidase
WHO Anatomical Therapeutic Chemical classification
0‑L
M05
Mittel zur Behandlung von Knochenerkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
M05B
Mittel mit Einfluss auf die Knochenstruktur und die Mineralisation
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA
Bisphosphonate
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA01
Etidronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA02
Clodronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA03
Pamidronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA04
Alendronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA05
Tiludronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA06
Ibandronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA07
Risedronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BA08
Zoledronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BB
Bisphosphonate, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BB01
Etidronsäure und Calcium, Sequenzialpräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BB02
Risedronsäure und Calcium, Sequenzialpräparat
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BB03
Alendronsäure und Colecalciferol
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BC
Knochenmorphogene Proteine
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BC01
Dibotermin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BC02
Eptotermin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BX
Andere Mittel mit Einfluß auf die Knochenstruktur und die Mineralisation
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BX01
Ipriflavon
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BX02
Aluminiumhydroxychlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BX03
Strontium ranelat
WHO Anatomical Therapeutic Chemical classification
0‑L
M05BX04
Denosumab
WHO Anatomical Therapeutic Chemical classification
0‑L
M09
Andere Mittel gegen Störungen des Muskel- und Skelettsystems
WHO Anatomical Therapeutic Chemical classification
0‑L
M09A
Andere Mittel gegen Störungen des Muskel- und Skelettsystems
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AA
Chinin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AA01
Hydrochinin
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AA72
Chinin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AB
Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AB01
Chymopapain
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AB02
Kollagenase aus Clostridium histolyticum
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AB52
Trypsin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AX
Andere Mittel gegen Störungen des Muskel- und Skelettsystems
WHO Anatomical Therapeutic Chemical classification
0‑L
M09AX01
Hyaluronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N
Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
N01
Anästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01A
Allgemeinanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AA
Ether
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AA01
Diethylether
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AA02
Vinylether
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB
Halogenierte Kohlenwasserstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB01
Halothan
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB02
Chloroform
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB03
Methoxyfluran
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB04
Enfluran
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB05
Trichlorethylen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB06
Isofluran
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB07
Desfluran
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AB08
Sevofluran
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AF
Barbiturate, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AF01
Methohexital
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AF02
Hexobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AF03
Thiopental
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AG
Barbiturate in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AG01
Narcobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH
Opioidanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH01
Fentanyl
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH02
Alfentanil
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH03
Sufentanil
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH04
Phenoperidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH05
Anileridin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH06
Remifentanil
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AH51
Fentanyl, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX
Andere Allgemeinanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX01
Droperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX03
Ketamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX04
Propanidid
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX05
Alfaxalon
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX07
Etomidate
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX10
Propofol
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX11
Hydroxybuttersäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX13
Distickstoffmonoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX14
Esketamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX15
Xenon
WHO Anatomical Therapeutic Chemical classification
0‑L
N01AX63
Distickstoffmonoxid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01B
Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA
Ester der Aminobenzoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA01
Metabutethamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA02
Procain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA03
Tetracain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA04
Chloroprocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA05
Benzocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BA52
Procain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB
Amide
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB01
Bupivacain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB02
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB03
Mepivacain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB04
Prilocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB05
Butanilicain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB06
Cinchocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB07
Etidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB08
Articain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB09
Ropivacain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB10
Levobupivacain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB51
Bupivacain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB52
Lidocain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB53
Mepivacain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB54
Prilocain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB57
Etidocain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BB58
Articain, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BC
Ester der Benzoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BC01
Cocain
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BX
Andere Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BX01
Ethylchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BX02
Dyclonin
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BX03
Phenol
WHO Anatomical Therapeutic Chemical classification
0‑L
N01BX04
Capsaicin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02
Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02A
Opioide
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA
Natürliche Opium-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA01
Morphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA02
Opium
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA03
Hydromorphon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA04
Nicomorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA05
Oxycodon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA08
Dihydrocodein
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA09
Diamorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA10
Papaveretum
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA51
Morphin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA55
Oxycodon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA58
Dihydrocodein, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA59
Codein, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AA79
Codein, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB
Phenylpiperidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB01
Ketobemidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB02
Pethidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB03
Fentanyl
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB52
Pethidin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AB72
Pethidin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC
Diphenylpropylamin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC01
Dextromoramid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC03
Piritramid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC04
Dextropropoxyphen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC05
Bezitramid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC52
Methadon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC54
Dextropropoxyphen, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AC74
Dextropropoxyphen, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AD
Benzomorphan-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AD01
Pentazocin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AD02
Phenazocin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AE
Oripavin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AE01
Buprenorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AF
Morphinan-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AF01
Butorphanol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AF02
Nalbufin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AG
Opioide in Kombination mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AG01
Morphin mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AG02
Ketobemidon mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AG03
Pethidin mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AG04
Hydromorphon mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX
Andere Opioide
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX01
Tilidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX02
Tramadol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX03
Dezocin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX06
Tapentadol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02AX52
Tramadol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02B
Andere Analgetika und Antipyretika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA
Salicylsäure und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA01
Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA02
Aloxiprin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA03
Cholinsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA04
Natriumsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA05
Salicylamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA06
Salsalat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA07
Ethenzamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA08
Morpholinsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA09
Dipyrocetyl
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA10
Benorilat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA11
Diflunisal
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA12
Kaliumsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA14
Guacetisal
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA15
Carbasalat calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA16
Imidazolsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA51
Acetylsalicylsäure, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA55
Salicylamid, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA57
Ethenzamid, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA59
Dipyrocetyl, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA65
Carbasalat calcium, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA71
Acetylsalicylsäure, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA75
Salicylamid, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA77
Ethenzamid, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BA79
Dipyrocetyl, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB
Pyrazolone
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB01
Phenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB02
Metamizol-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB03
Aminophenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB04
Propyphenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB05
Nifenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB51
Phenazon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB52
Metamizol-Natrium, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB53
Aminophenazon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB54
Propyphenazon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB71
Phenazon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB72
Metamizol-Natrium, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB73
Aminophenazon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BB74
Propyphenazon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE
Anilide
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE01
Paracetamol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE03
Phenacetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE04
Bucetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE05
Propacetamol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE51
Paracetamol, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE53
Phenacetin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE54
Bucetin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE71
Paracetamol, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE73
Phenacetin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BE74
Bucetin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG
Andere Analgetika und Antipyretika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG02
Rimazolium
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG03
Glafenin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG04
Floctafenin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG05
Viminol
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG06
Nefopam
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG07
Flupirtin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG08
Ziconotid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02BG10
Nabiximols
WHO Anatomical Therapeutic Chemical classification
0‑L
N02C
Migränemittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA
Mutterkorn-Alkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA01
Dihydroergotamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA02
Ergotamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA04
Methysergid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA07
Lisurid
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA51
Dihydroergotamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA52
Ergotamin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CA72
Ergotamin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CB
Corticosteroid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CB01
Flumedroxon
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC
Selektive Serotonin-5HT1-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC01
Sumatriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC02
Naratriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC03
Zolmitriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC04
Rizatriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC05
Almotriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC06
Eletriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CC07
Frovatriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX
Andere Migränemittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX01
Pizotifen
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX02
Clonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX03
Iprazochrom
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX05
Dimetotiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N02CX06
Oxetoron
WHO Anatomical Therapeutic Chemical classification
0‑L
N03
Antiepileptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N03A
Antiepileptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA
Barbiturate und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA01
Methylphenobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA02
Phenobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA03
Primidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA04
Barbexaclon
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AA30
Metharbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB
Hydantoin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB01
Ethotoin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB02
Phenytoin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB03
Amino(diphenylhydantoin)valeriansäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB04
Mephenytoin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB05
Fosphenytoin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB52
Phenytoin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AB54
Mephenytoin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AC
Oxazolidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AC01
Paramethadion
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AC02
Trimethadion
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AC03
Ethadion
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AD
Succinimid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AD01
Ethosuximid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AD02
Phensuximid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AD03
Mesuximid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AD51
Ethosuximid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AE
Benzodiazepin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AE01
Clonazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AF
Carboxamid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AF01
Carbamazepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AF02
Oxcarbazepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AF03
Rufinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AF04
Eslicarbazepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG
Fettsäure-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG01
Valproinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG02
Valpromid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG03
Aminobuttersäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG04
Vigabatrin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG05
Progabid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AG06
Tiagabin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX
Andere Antiepileptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX03
Sultiam
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX07
Phenacemid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX09
Lamotrigin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX10
Felbamat
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX11
Topiramat
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX12
Gabapentin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX13
Pheneturid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX14
Levetiracetam
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX15
Zonisamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX16
Pregabalin
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX17
Stiripentol
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX18
Lacosamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX22
Perampanel
WHO Anatomical Therapeutic Chemical classification
0‑L
N03AX30
Beclamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N04
Antiparkinsonmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N04A
Anticholinergika
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA
Tertiäre Amine
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA01
Trihexyphenidyl
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA02
Biperiden
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA03
Metixen
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA04
Procyclidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA05
Profenamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA08
Dexetimid
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA09
Phenglutarimid
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA10
Mazaticol
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA11
Bornaprin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AA12
Tropatepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AB
Ether, chemisch den Antihistaminika verwandt
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AB01
Etanautin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AB02
Orphenadrin (chlorid)
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AC
Tropinether oder Tropin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AC01
Benzatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04AC30
Etybenzatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04B
Dopaminerge Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA
Dopa und Dopa-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA01
Levodopa
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA02
Levodopa und Decarboxylasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA03
Levodopa, Decarboxylasehemmer und COMT-Hemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA04
Melevodopa
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA05
Melevodopa und Decarboxylasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BA06
Etilevodopa und Decarboxylasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BB
Adamantan-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BB01
Amantadin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC
Dopamin-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC01
Bromocriptin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC02
Pergolid
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC03
Dihydroergocryptinmesilat
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC04
Ropinirol
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC05
Pramipexol
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC06
Cabergolin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC07
Apomorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC08
Piribedil
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BC09
Rotigotin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BD
Monoaminoxidase-B-Hemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BD01
Selegilin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BD02
Rasagilin
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BX
Andere dopaminerge Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BX01
Tolcapon
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BX02
Entacapon
WHO Anatomical Therapeutic Chemical classification
0‑L
N04BX03
Budipin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05
Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N05A
Antipsychotika
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA
Phenothiazine mit aliphatischer Seitenkette
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA01
Chlorpromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA02
Levomepromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA03
Promazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA04
Acepromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA05
Triflupromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA06
Cyamemazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AA07
Chlorproethazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB
Phenothiazine mit Piperazinstruktur
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB01
Dixyrazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB02
Fluphenazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB03
Perphenazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB04
Prochlorperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB05
Thiopropazat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB06
Trifluoperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB07
Acetophenazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB08
Thioproperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB09
Butaperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AB10
Perazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AC
Phenothiazine mit Piperidinstruktur
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AC01
Periciazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AC02
Thioridazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AC03
Mesoridazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AC04
Pipotiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD
Butyrophenon-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD01
Haloperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD02
Trifluperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD03
Melperon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD04
Moperon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD05
Pipamperon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD06
Bromperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD07
Benperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD08
Droperidol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AD09
Fluanison
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AE
Indol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AE01
Oxypertin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AE02
Molindon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AE03
Sertindol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AE04
Ziprasidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF
Thioxanthen-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF01
Flupentixol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF02
Clopenthixol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF03
Chlorprothixen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF04
Tiotixen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AF05
Zuclopenthixol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AG
Diphenylbutylpiperidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AG01
Fluspirilen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AG02
Pimozid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AG03
Penfluridol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH
Diazepine, Oxazepine und Thiazepine
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH01
Loxapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH02
Clozapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH03
Olanzapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH04
Quetiapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AH05
Asenapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AK
Neuroleptika bei Spätdyskinesien
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AK01
Tetrabenazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL
Benzamide
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL01
Sulpirid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL02
Sultoprid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL03
Tiaprid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL04
Remoxiprid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL05
Amisulprid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL06
Veraliprid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AL07
Levosulpirid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AN
Lithium
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AN01
Lithium
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX
Andere Antipsychotika
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX07
Prothipendyl
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX08
Risperidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX09
Clotiapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX10
Mosapramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX11
Zotepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX12
Aripiprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05AX13
Paliperidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05B
Anxiolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA
Benzodiazepin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA01
Diazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA02
Chlordiazepoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA03
Medazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA04
Oxazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA05
Dikaliumclorazepat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA06
Lorazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA07
Adinazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA08
Bromazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA09
Clobazam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA10
Ketazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA11
Prazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA12
Alprazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA13
Halazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA14
Pinazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA15
Camazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA16
Nordazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA17
Fludiazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA18
Ethylloflazepat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA19
Etizolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA21
Clotiazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA22
Cloxazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA23
Tofisopam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BA56
Lorazepam, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BB
Diphenylmethan-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BB01
Hydroxyzin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BB02
Captodiam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BB51
Hydroxyzin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BC
Carbamate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BC01
Meprobamat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BC03
Emylcamat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BC04
Mebutamat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BC51
Meprobamat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BD
Dibenzo-bicyclo-octadien-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BD01
Benzoctamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BE
Azaspirodecandion-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BE01
Buspiron
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BX
Andere Anxiolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BX01
Mephenoxalon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BX02
Gedocarnil
WHO Anatomical Therapeutic Chemical classification
0‑L
N05BX03
Etifoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05C
Hypnotika und Sedativa
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA
Barbiturate, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA01
Pentobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA02
Amobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA03
Butobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA04
Barbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA05
Aprobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA06
Secobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA07
Talbutal
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA08
Vinylbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA09
Vinbarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA10
Cyclobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA11
Heptabarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA12
Reposal
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA15
Methohexital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA16
Hexobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA19
Thiopental
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA20
Etallobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA21
Allobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CA22
Proxibarbal
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CB
Barbiturate, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CB01
Kombinationen von Barbituraten
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CB02
Barbiturate in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC
Aldehyde und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC01
Chloralhydrat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC02
Chloralodol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC03
Acetylglycinamidchloralhydrat
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC04
Dichloralphenazon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CC05
Paraldehyd
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD
Benzodiazepin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD01
Flurazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD02
Nitrazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD03
Flunitrazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD04
Estazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD05
Triazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD06
Lormetazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD07
Temazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD08
Midazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD09
Brotizolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD10
Quazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD11
Loprazolam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD12
Doxefazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CD13
Cinolazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CE
Piperidindion-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CE01
Glutethimid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CE02
Methyprylon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CE03
Pyrithyldion
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CF
Benzodiazepin-verwandte Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CF01
Zopiclon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CF02
Zolpidem
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CF03
Zaleplon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM
Andere Hypnotika und Sedativa
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM01
Methaqualon
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM02
Clomethiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM03
Bromisoval
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM04
Carbromal
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM05
Scopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM06
Propiomazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM07
Triclofos
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM08
Ethchlorvynol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM09
Baldrian
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM10
Hexapropymate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM11
Bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM12
Apronal
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM13
Valnoctamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM15
Methylpentynol
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM16
Niaprazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM17
Melatonin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CM18
Dexmedetomidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX
Hypnotika und Sedativa in Kombination, exkl. Barbiturate
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX01
Meprobamat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX02
Methaqualon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX03
Methylpentynol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX04
Clomethiazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX05
Emepronium, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N05CX06
Dipiperonylaminoethanol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N06
Psychoanaleptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06A
Antidepressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA
Nichtselektive Monoamin-Wiederaufnahmehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA01
Desipramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA02
Imipramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA03
Imipraminoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA04
Clomipramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA05
Opipramol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA06
Trimipramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA07
Lofepramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA08
Dibenzepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA09
Amitriptylin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA10
Nortriptylin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA11
Protriptylin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA12
Doxepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA13
Iprindol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA14
Melitracen
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA15
Butriptylin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA16
Dosulepin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA17
Amoxapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA18
Dimetacrin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA19
Amineptin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA21
Maprotilin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AA23
Quinupramin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB
Selektive Serotonin-Wiederaufnahmehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB02
Zimeldin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB03
Fluoxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB04
Citalopram
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB05
Paroxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB06
Sertralin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB07
Alaproclat
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB08
Fluvoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB09
Etoperidon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AB10
Escitalopram
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AC
N06AC
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AD
N06AD
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AE
N06AE
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF
Monoaminoxidasehemmer, nichtselektiv
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF01
Isocarboxazid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF02
Nialamid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF03
Phenelzin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF04
Tranylcypromin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF05
Iproniazid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AF06
Iproclozid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AG
Monoaminoxidase-A-Hemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AG02
Moclobemid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AG03
Toloxaton
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX
Andere Antidepressiva
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX01
Oxitriptan
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX02
Tryptophan
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX03
Mianserin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX04
Nomifensin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX05
Trazodon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX06
Nefazodon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX07
Minaprin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX08
Bifemelan
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX09
Viloxazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX10
Oxaflozan
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX11
Mirtazapin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX12
Bupropion
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX13
Medifoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX14
Tianeptin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX15
Pivagabin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX16
Venlafaxin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX17
Milnacipran
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX18
Reboxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX19
Gepiron
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX21
Duloxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX22
Agomelatin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX23
Desvenlafaxin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06AX25
Hyperici herba
WHO Anatomical Therapeutic Chemical classification
0‑L
N06B
Psychostimulanzien, Mittel für die ADHD und Nootropika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA
Zentral wirkende Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA01
Amfetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA02
Dexamfetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA03
Metamfetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA04
Methylphenidat
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA05
Pemolin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA06
Fencamfamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA07
Modafinil
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA08
Fenozolon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA09
Atomoxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BA10
Fenetyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BC
Xanthin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BC01
Coffein
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BC02
Propentofyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX
Andere Psychostimulanzien und Nootropika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX01
Meclofenoxat
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX02
Pyritinol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX03
Piracetam
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX04
Deanol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX05
Fipexid
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX06
Citicolin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX07
Oxiracetam
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX08
Pirisudanol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX09
Linopirdin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX10
Nizofenon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX11
Aniracetam
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX12
Acetylcarnitin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX13
Idebenon
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX14
Prolintan
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX15
Pipradrol
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX16
Pramiracetam
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX17
Adrafinil
WHO Anatomical Therapeutic Chemical classification
0‑L
N06BX18
Vinpocetin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06C
Psycholeptikau und Psychoanaleptika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
N06CA
Antidepressiva in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06CA01
Amitriptylin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06CA02
Melitracen und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06CB
Psychostimulanzien in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
N06D
Antidementiva
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DA
Cholinesterasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DA01
Tacrin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DA02
Donepezil
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DA03
Rivastigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DA04
Galantamin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DX
Andere Antidementiva
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DX01
Memantin
WHO Anatomical Therapeutic Chemical classification
0‑L
N06DX02
Ginkgo biloba
WHO Anatomical Therapeutic Chemical classification
0‑L
N07
Andere Mittel für das Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
N07A
Parasympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA
Cholinesterasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA01
Neostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA02
Pyridostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA03
Distigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA30
Ambenonium
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AA51
Neostigmin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AB
Cholinester
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AB01
Carbachol
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AB02
Bethanechol
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AX
Andere Parasympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AX01
Pilocarpin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07AX02
Cholinalfoscerat
WHO Anatomical Therapeutic Chemical classification
0‑L
N07B
Mittel zur Behandlung von Suchterkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BA
Mittel zur Behandlung der Nikotinabhängigkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BA01
Nicotin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BA02
Bupropion
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BA03
Vareniclin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BB
Mittel zur Behandlung der Alkoholabhängigkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BB01
Disulfiram
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BB02
Calcium carbimid
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BB03
Acamprosat
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BB04
Naltrexon
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC
Mittel zur Behandlung der Opiatabhängigkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC01
Buprenorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC02
Methadon
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC03
Levacetylmethadol
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC04
Lofexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07BC51
Buprenorphin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N07C
Antivertiginosa
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA
Antivertiginosa
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA01
Betahistin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA02
Cinnarizin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA03
Flunarizin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA04
Acetylleucin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07CA52
Cinnarizin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
N07X
Andere Mittel für das Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XA
Ganglioside und Gangliosid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX
Andere Mittel für das Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX01
Tirilazad
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX02
Riluzol
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX03
Xaliproden
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX04
Hydroxybuttersäure
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX05
Amifampridin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX06
Tetrabenazin
WHO Anatomical Therapeutic Chemical classification
0‑L
N07XX07
Fampridin
WHO Anatomical Therapeutic Chemical classification
0‑L
P
Antiparasitäre Mittel, Insektizide und Repellenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
P01
Mittel gegen Protozoen-Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01A
Mittel gegen Amöben und andere Protozoen-Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA
Hydroxychinolin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA01
Broxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA02
Clioquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA04
Chlorquinaldol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA05
Tilbroquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AA52
Clioquinol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB
Nitroimidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB01
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB02
Tinidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB03
Ornidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB04
Azanidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB05
Propenidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB06
Nimorazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AB07
Secnidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AC
Dichloracetamid-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AC01
Diloxanid
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AC02
Clefamid
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AC03
Etofamid
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AC04
Teclosan
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AR
Arsen-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AR01
Arsthinol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AR02
Difetarson
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AR03
Glycobiarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AR53
Glycobiarsol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX
Andere Mittel gegen Amöbiasis und andere Protozoen-Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX01
Chiniofon
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX02
Emetin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX04
Phanquinon
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX05
Mepacrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX06
Atovaquon
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX07
Trimetrexat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX08
Tenonitrozol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX09
Dehydroemetin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX10
Fumagillin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01AX52
Emetin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01B
Malariamittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BA
Aminochinoline
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BA01
Chloroquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BA02
Hydroxychloroquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BA03
Primaquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BA06
Amodiaquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BB
Biguanide
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BB01
Proguanil
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BB02
Cycloguanilembonat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BB51
Proguanil, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BC
Methanolchinoline
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BC01
Chinin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BC02
Mefloquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BD
Diaminopyrimidine
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BD01
Pyrimethamin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BD51
Pyrimethamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE
Artemisinin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE01
Artemisinin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE02
Artemether
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE03
Artesunat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE04
Artemotil
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE05
Artenimol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BE52
Artemether, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BF01
Artemether und Lumefantrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BF05
Artenimol und Piperaquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BX
Andere Malariamittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P01BX01
Halofantrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P01C
Mittel gegen Leishmaniasis und Trypanosomiasis
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CA
Nitroimidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CA02
Benznidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CB
Antimon-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CB01
Megluminantimonat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CB02
Natriumstibogluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CC
Nitrofuran-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CC01
Nifurtimox
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CC02
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CD
Arsen-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CD01
Melarsoprol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CD02
Acetarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CX
Andere Mittel gegen Leishmaniasis und Trypanosomiasis
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CX01
Pentamidinisethionat
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CX02
Suramin natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
P01CX03
Eflornithin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02
Anthelmintika
WHO Anatomical Therapeutic Chemical classification
0‑L
P02B
Trematodenmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BA
Chinolin-Derivate und verwandte Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BA01
Praziquantel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BA02
Oxamniquin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BB
Organophosphat-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BB01
Metrifonat
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BX
Andere Trematodenmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BX01
Bithionol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BX02
Niridazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BX03
Stibophen
WHO Anatomical Therapeutic Chemical classification
0‑L
P02BX04
Triclabendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02C
Nematodenmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA
Benzimidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA01
Mebendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA02
Tiabendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA03
Albendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA04
Ciclobendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA05
Flubendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA06
Fenbendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CA51
Mebendazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CB
Piperazin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CB01
Piperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CB02
Diethylcarbamazin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CC
Tetrahydropyrimidin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CC01
Pyrantel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CC02
Oxantel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CE
Imidazothiazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CE01
Levamisol
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CF
Avermektine
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CF01
Ivermectin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CX
Andere Nematodenmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CX01
Pyrvinium
WHO Anatomical Therapeutic Chemical classification
0‑L
P02CX02
Bephenium
WHO Anatomical Therapeutic Chemical classification
0‑L
P02D
Bandwurmmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02DA
Salicylsäure-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
P02DA01
Niclosamid
WHO Anatomical Therapeutic Chemical classification
0‑L
P02DX
Andere Bandwurmmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P02DX01
Desaspidin
WHO Anatomical Therapeutic Chemical classification
0‑L
P02DX02
Dichlorophen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03
Mittel gegen Ektoparasiten, inkl. Antiscabiosa, Insektizide und Repellenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
P03A
Mittel gegen Ektoparasiten, inkl. Antiscabiosa
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA
Schwefel-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA01
Dixanthogen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA02
Kaliumpolysulfid
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA03
Mesulfen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA04
Disulfiram
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA05
Thiram
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AA54
Disulfiram, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AB
Chlor-haltige Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AB01
Clofenotan
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AB02
Lindan
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AB51
Clofenotan, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC
Pyrethrine, inkl. synthetische Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC01
Pyrethrum
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC02
Bioallethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC03
Phenothrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC04
Permethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC51
Pyrethrum, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC52
Bioallethrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC53
Phenothrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AC54
Permethrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AX
Andere Mittel gegen Ektoparasiten, inkl. Antiscabiosa
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AX01
Benzylbenzoat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AX02
Kupferoleat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AX03
Malathion
WHO Anatomical Therapeutic Chemical classification
0‑L
P03AX04
Quassia
WHO Anatomical Therapeutic Chemical classification
0‑L
P03B
Insektizide und Repellenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BA
Pyrethrine
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BA01
Cyfluthrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BA02
Cypermethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BA03
Decamethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BA04
Tetramethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX
Andere Insektizide und Repellenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX01
Diethyltoluamid
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX02
Dimethylphthalat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX03
Dibutylphthalat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX04
Dibutylsuccinat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX05
Dimethylcarbat
WHO Anatomical Therapeutic Chemical classification
0‑L
P03BX06
Etohexadiol
WHO Anatomical Therapeutic Chemical classification
0‑L
P52AF03
Oxantel
WHO Anatomical Therapeutic Chemical classification
0‑L
P52AG09
Closantel Natrium Dihydrat für Tiere
WHO Anatomical Therapeutic Chemical classification
0‑L
P53AX25
Metaflumizon
WHO Anatomical Therapeutic Chemical classification
0‑L
Q
veterinär ATC
WHO Anatomical Therapeutic Chemical classification
0‑L
QA02BC01
Omeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03AB91
Synthetische Anticholinergika, quaternäre Ammoniumverbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03AX
andere Medikamente für funktionelle Darmstörung
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03AX13
Silikone
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03BB01
Butylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03DB04
Butylscopolamin und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
QA03FA01
Metoclopramid
WHO Anatomical Therapeutic Chemical classification
0‑L
QA04AD90
Maropitant
WHO Anatomical Therapeutic Chemical classification
0‑L
QA05AX90
Menbuton
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07AA06
Paromomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07AA10
Colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07AA51
Neomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07AA91
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07AA99
Antibiotika, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07BB
Bismuth Präparate
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07BC30
Kombinationen, andere intestinale Adsorbentien
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07CQ
Orale Elektrolyte und Kohlenhydrate
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07FA01
Milchsäurebildner
WHO Anatomical Therapeutic Chemical classification
0‑L
QA07XA91
Zinkoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
QA08AB90
Mitratapid
WHO Anatomical Therapeutic Chemical classification
0‑L
QA08AB91
Dirlotapide
WHO Anatomical Therapeutic Chemical classification
0‑L
QA10AC03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11A
Multivitamine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11AB
Multivitamins, other combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11CC05
Colecalciferol
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11HA
andere Vitaminpräparate, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11JA
Kombinationen von Vitaminen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA11JC
Vitamine, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12
andere Mineralstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12AA03
Calciumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12AA07
Calciumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12AX
Calcium, Kombinationen mit Vitamin D und/oder anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12CE99
Selen-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12CX91
Butafosfan
WHO Anatomical Therapeutic Chemical classification
0‑L
QA12CX99
andere Mineralstoffe, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QA16Q
Präparate zur Prävention und/oder Behandlung von Acetonämie
WHO Anatomical Therapeutic Chemical classification
0‑L
QA16QA06
Monensin
WHO Anatomical Therapeutic Chemical classification
0‑L
QB02BA01
Phytomenadion
WHO Anatomical Therapeutic Chemical classification
0‑L
QB03AA02
Eisen(II)fumarat
WHO Anatomical Therapeutic Chemical classification
0‑L
QB03AC
Eisen dreiwertig, parenterale Präparate
WHO Anatomical Therapeutic Chemical classification
0‑L
QB03AC06
ferric oxide dextran complexes
WHO Anatomical Therapeutic Chemical classification
0‑L
QB03AC90
Eisen Dextran Komplex
WHO Anatomical Therapeutic Chemical classification
0‑L
QB03AC91
Gleptoferron
WHO Anatomical Therapeutic Chemical classification
0‑L
QB05AA90
Blutsubstitut und Plasmaprotein-Fraktion
WHO Anatomical Therapeutic Chemical classification
0‑L
QB05B
I.V.-Lösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
QB05BB
Lösungen für Elektrolytenhaushalt
WHO Anatomical Therapeutic Chemical classification
0‑L
QB05BB01
Elektrolyte
WHO Anatomical Therapeutic Chemical classification
0‑L
QB05XA30
Kombinationen von Elektrolyten
WHO Anatomical Therapeutic Chemical classification
0‑L
QC01CE90
Pimobendan
WHO Anatomical Therapeutic Chemical classification
0‑L
QC03AA56
Trichlormethiazide Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QC03CA01
Furosemid
WHO Anatomical Therapeutic Chemical classification
0‑L
QC03DA01
Spironolacton
WHO Anatomical Therapeutic Chemical classification
0‑L
QC04AD90
Propentofyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09AA02
Enalapril
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09AA05
Ramipril
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09AA07
Benazepril
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09AA16
Imidapril
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09BA07
Benazepril und Diuretika
WHO Anatomical Therapeutic Chemical classification
0‑L
QC09CA07
Telmisartan
WHO Anatomical Therapeutic Chemical classification
0‑L
QD
Dermatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
QD01AA20
Antibiotika, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QD01AC90
Enilconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QD01AE20
Kombinationen, Antimykotika für topische Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
QD02AX
Andere Emollentia und Hautschutzmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
QD03AX90
Ketanserin
WHO Anatomical Therapeutic Chemical classification
0‑L
QD06A
Antibiotika für topische Anwendungen
WHO Anatomical Therapeutic Chemical classification
0‑L
QD06AA02
Chlortetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
QD06AA03
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
QD07AC
Corticosteroide, stark wirksam (Gruppe III)
WHO Anatomical Therapeutic Chemical classification
0‑L
QD07AC16
Hydrocortisonaceponat
WHO Anatomical Therapeutic Chemical classification
0‑L
QD07AC90
Resocortolbutyrat
WHO Anatomical Therapeutic Chemical classification
0‑L
QD07CC01
Betamethason und Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QD07X
Kortikosteroide, sehr potent, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08
Antiseptika und Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08A
Antiseptika und Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AC02
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AC52
Chlorhexidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AE02
Policresulen
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AG02
Povidon Jod
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AG03
Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
QD08AX
Antiseptika und Desinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
QG01AX
andere Antiinfektiva und Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
QG02AD01
Dinoprost
WHO Anatomical Therapeutic Chemical classification
0‑L
QG02AD90
Cloprostenol
WHO Anatomical Therapeutic Chemical classification
0‑L
QG02AD91
Luprostiol
WHO Anatomical Therapeutic Chemical classification
0‑L
QG02CB01
Bromocriptin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG02CB03
Cabergolin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03AC06
Medroxyprogesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03CA04
Estriol
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03DA04
Progesteron
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03DA90
Proligeston
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03DB06
Chlormadinon
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03DX90
Altrenogest
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03DX91
Delmadinone
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03GA01
Chorion-Gonadotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03GA03
Serum-Gonadotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03GA90
Follikel stimulierende Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03GA99
Gonadotropine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03GB
synthetische Eisprungstimulanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03XA91
Gonadotropin-Releasing-Faktor-Analogon, konjugiert
WHO Anatomical Therapeutic Chemical classification
0‑L
QG03XB90
Aglepriston
WHO Anatomical Therapeutic Chemical classification
0‑L
QG04BX91
Phenylpropanolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG04CX
Arzneimittel zur Behandlung der benignen Prostatahypertrophie
WHO Anatomical Therapeutic Chemical classification
0‑L
QG51A
Antiinfektiva und Antiseptika für die intrauterine Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
QG51AA
Antibakterielle Wirkstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
QG51AA02
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
QG51AA09
Formosulfathiazol (intrauterin)
WHO Anatomical Therapeutic Chemical classification
0‑L
QG51AA30
Antibiotika-Kombinationen zur intrauterinen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
QG52A
Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
QG52X
diverse Produkte für Zitzen und Euter
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01BB02
Oxytocin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01BB03
Carbetocin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01CA
Gonadotropin-Releasing-Hormone
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01CA01
Gonadorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01CA90
Buserelin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01CA92
Lecirelin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH01CA93
Deslorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
QH02AB01
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
QH02AB02
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
QH02AB56
Prednisolon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QH02CA01
Trilostan
WHO Anatomical Therapeutic Chemical classification
0‑L
QH03AA01
Levothyroxin-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
QH03BB01
Carbimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QH03BB02
Thiamazole
WHO Anatomical Therapeutic Chemical classification
0‑L
QI
Immunologika
WHO Anatomical Therapeutic Chemical classification
0‑L
QI 09AB07
Tocopherolacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01
Immunologika für Aves
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA03
aviäre Infektiöse Bronchitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA06
aviäres infektiöse Bronchitis Virus + aviäres infekt.Bursitis (Gumboro) Virus + Newcastle Disease Virus/Paramyxo-Virus + aviäres Rhinotracheitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA13
Newcastle Disease Virus / Paramyxvirus + aviäre infektiöse Bronchitis Virus + aviäre Adenovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA17
aviäre Rhinotracheitis-Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA18
aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Adenovirus + aviäre Rhinotracheitisvirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA21
aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Rhinotracheitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AA23
aviäres Influenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB
Inaktivierter bakterieller Impfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB01
Salmonella
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB02
Pasteurella
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB05
Escherichia (Aves)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB07
Ornithobacterium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AB08
Clostridium (Aves)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD
aviärer lebend Virus-Impfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD01
avian rhinotracheitis virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD02
aviäre Enzephalomyelitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD03
Aviäres Herpesvirus (Mareksche Krankheit)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD04
Hühner Anaemie Virus (CIA)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD06
Newcastle Disease Virus / Paramyxovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD07
aviäres Infektiöse Bronchitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD08
Infektiöse Laryngotracheitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD09
avian infectious bursal disease virus (gumboro disease)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AD15
aviärs infektiöses Bursitis Virus (Gumboro) + aviäres Herpesvirus (Marek-Krankheit)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AE
Bakterieller Lebendimpfstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AE01
Salmonella
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AE03
Mycoplasma (Aves)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AE04
Escherichia (Aves)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01AN01
Kokzidien
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01BE
bakterieller Lebendimpfstoff für Ente
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01CA
inaktivierter viraler Impfstoff für Puten
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01CD01
Rhinotracheitisvirus, Puten-
WHO Anatomical Therapeutic Chemical classification
0‑L
QI01EA01
Paramyxovirus (Tauben)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02
Immunologika für Bovidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AA01
Bovinen Virusdiarrhoe
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AA02
Boviner respiratorische Syncytialvirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AA03
Bovine Rhinotracheitis Virus (IBR)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AA04
Maul- und Klauenseuchen Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AA08
Blauzungen Virus (Bovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AB
Inaktivierte bakterielle Impfstoffe (inkl. Mycoplasma, Toxoid und Chlamydien) - Bovidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AB01
Clostridium (Bovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AB04
Pasteurella (Bovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AD01
Bovines Rhinotracheitis Virus (IBR)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AD07
Bovines Respiratorisches Synzytialvirus + Bovines Parainfluenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AI01
lebend bovines Rotavirus + lebend bovines Coronavirus + inakt. Escherichia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AL01
bovines Rotavirus + bovines Coronavirus + Escherichia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AL04
Bovines Parainfluenza Virus + Bovines Respiratorisches Synzytialvirus + Pasteurella
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AM05
bovine Rotavirus Antiserum + bovine Coronavirus Antiserum + Escherichia Antiserum
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AP01
Trichophyton
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AR01
bovines Tuberculin PPD
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AR02
aviäres Tuberculin PPD
WHO Anatomical Therapeutic Chemical classification
0‑L
QI02AT01
Escherichia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI03
Immunologika für Capridae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI03AB
Inaktiviere bakterielle Impfung (inkl. Mycoplasma, Toxoid und Chlamydien) - Capridae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI03AC
Inaktivierte bakterielle Impfungen und Antisera
WHO Anatomical Therapeutic Chemical classification
0‑L
QI04
Immunologika für Ovidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI04AA02
Blauzungen Virus (Ovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI04AB01
Clostridium (Ovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI04AB03
Bacteroides (Ovidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05
Immunologika für Equidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AA
Virale Impfstoffe, inaktiviert
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AA01
equine Influenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AA04
equine Rhinopneumonitis-Virus + equine Influenzavirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AA05
Equines Rhinopneumonitis Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AA10
West Nile Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AB
inakt. bakterielle Impfung (inkl. Mycoplasma, Toxoid u. Chlamydien)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AB01
Streptococcen
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AB03
Clostridium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AD02
Equines Influenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AI01
Equines Influenza Virus + Clostridium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AL01
equine Influenza Virus + Clostridium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AM01
Clostridium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AQ
Trichophyton + Microsporum (Equidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI05AX
andere Immunologika (Equidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06
Immunologika für Felidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AA01
Feline Leukämievirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AA02
Feline Panleukopenie Virus / Parvovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AA04
felines Rhinotracheitis Virus + felines Calicivirus + felines Panleukopenie Virus / Parvovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AA06
Felines infektiöses Peritonitis (FIP) Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AA09
Panleukopenie + Calicivirus + Rhinotracheitis + Tollwut Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AD01
felines Panleukopenie Virus / Parvovirus (lebend viral)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AD03
felines Rhinotracheitisvirus und felines Calicivirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AD04
Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AE02
Bordetella (Felidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AF01
Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus + Chlamydia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH
Lebende und inaktivierte virale Impfungen (Felidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH04
lebend felines Panleukopenie Virus / Parovirus + inakt. Tollwut Virus + inakt. felines Rhinotracheitis Virus + inakt. felines Calicivirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH05
lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. Tollwut Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH07
lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. felines Leukaemie Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH08
lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AH09
lebend felines Rhinotracheitis Virus + lebend felines Panleukpenie Virus / Parvovirus + inakt. felines Calicivirus-Antigen
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AJ
lebende und inaktivierte virale und bakterielle Impfstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AJ02
lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend Chlamydien
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AJ03
lebend felinesRhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend felines Panleukopenie Virus / Parvovirus + lebend Chlamydien
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AL01
felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + felines infektiöse Leukaemie Virus + Chlamydia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI06AL02
felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + inakt. Chlamydia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07
Immunologika für Canidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AA01
Parvovirose Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AA02
Rabiesvirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AA06
Canines Herpes-Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AB01
Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AB04
Borrelia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AD01
canines Parvovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AD02
canines Staupe Virus + canines Adenovirus + canines Parvovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AD03
canines Staupe Virus + canines Parovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AD04
canines Staupe Virus + canines Adenovirus + canines Parvovirus + canines Parainfluenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AD08
canine Parainfluenza-Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AE01
Bordetella
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AF
Lebende bakterielle und virale Impfungen (Canidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AI01
lebend canines Staupevirus + lebend canines Adenovirus + inakt. Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AI02
lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parainfluenza Virus + lebend canines Parvovirus + inakt. Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ
Lebende virale und inaktivierte virale und bakterielle Impfungen (Canidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ01
Staupe Virus (lebend) + Adenovirus (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ02
Staupevirus (lebend) + Adenovirus (inakt.) + Leptospirose (inakt.) Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ03
Staup Virus (lebend) + Adenovirus (inakt.) + Parvovirus (inakt.) + Leptospirose (inakt.) Viren
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ04
Staupe Virus (lebend) + Adenovirus (inakt.) + Parvovirose (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ05
lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parvovirus + inakt. Tollwut Virus + inakt. Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ06
lebend canines Staupevirus + lebend canines Adenovirus + lebend Parainfluenzavirus + lebend canines Parvovirus + inakt. Tollwutvirus + inakt. Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AJ10
canine Staupe Virus (lebend) + canine Adenovirus (lebend) + Parainfluenza Virus (lebend) + canine Parvovirus (lebend) + canine Coronavirus (inakt.) + Leptospira (inakt.)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AL01
Tollwut Virus + Leptospira
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AL05
Bordetella + Parainfluenza Virus (Canidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07AO
Inaktivierte Impfungen gegen Parasiten
WHO Anatomical Therapeutic Chemical classification
0‑L
QI07BD
lebend viraler Impfstoff (Fuchs)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI08
Immunologika für Leporidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI08AA01
Haemorrhagie-Virus (Kaninchen)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI08AD
viraler Lebendimpfstoff (Leporidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI08AD02
Myxomatose Virus (Leporidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09
Immunologika für Suidae
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AA02
porcines Parvovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AA03
Porcine Influenza Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AA05
Schweine-reproduktive und respiratorische Syndrom (PRRS)-Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AA06
Europäisches Schweinepestvirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AA07
Porcines Circovirus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB02
Escherichia (Suidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB03
Erysipelothrix
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB04
Bordetella + Pasteurella (Suidae)
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB07
Actinobacillus/Haemophilus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB08
Escherichia + Clostridium
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB13
Mycoplasma
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AB17
Mykoplasmen + Haemophilus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AD01
Aujeszkyʹscher Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AD03
PRRS-Virus
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AE04
Lawsonia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI09AL01
porcines Parvovirus + Erysipelothrix
WHO Anatomical Therapeutic Chemical classification
0‑L
QI10
Immunologika für Pisces
WHO Anatomical Therapeutic Chemical classification
0‑L
QI10AB01
Aeromonas
WHO Anatomical Therapeutic Chemical classification
0‑L
QI10BB03
Yersinia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI11
Immunologika für Rodentia
WHO Anatomical Therapeutic Chemical classification
0‑L
QI20
Andere Immunologika (Bienen, Frettchen, Nerz,...)
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA02
Doxycyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA03
Chlortetrazyklin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA06
Oxytetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA09
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA53
Chlortetracyclin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01AA56
oxytetracycline, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01BA01
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01BA02
Thiamphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01BA90
Florfenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01BA99
Amfenicol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CA
Penicilline mit erweitertem Spektrum
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CA01
Ampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CA04
Amoxicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CE02
Phenoxymethylpenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CE09
Procain-Penicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CE90
Penethamat Hydroiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01CR02
Amoxicillin und Enzyminhibitor
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01DB01
Cefalexin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01DD90
Ceftiofur
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01DD91
Cefovecin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01DE90
Cefquinom
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EQ03
Sulfadimidine
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EW03
Sulfadimidin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EW10
Sulfadiazin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EW11
Sulfamethoxazol und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EW12
Sulfachlorpyridazin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01EW13
Sulfadoxin und Trimethoprim
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA02
Spiramycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA90
Tylosin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA91
Tilmicosin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA92
Tylvalosin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA94
Tulathromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA95
Gamithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FA96
Tildipirosin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FF01
Clindamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01FF52
Lincomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01GA90
Dihydrostreptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01GB03
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01GB04
Kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01GB05
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01GB90
Apramycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA90
Enrofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA92
Danofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA93
Marbofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA94
Difloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA95
Orbifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA96
Ibafloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01MA97
Pardofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01RA01
Penicilline, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01RA02
Sulfonamide, Kombinationen mit anderen Antibiotika (exkl.Trimethoprim)
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01RA04
Spiramycin, Kombination mit anderen antibakteriellen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01RA91
Makrolide, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01XB01
Colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01XQ01
Tiamulin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01XQ02
Valnemulin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ01XX92
Tiamulin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ02AC02
Itraconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51CA51
Ampicillin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51CE09
Procaine-Benzylpenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51CF02
Cloxacillin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51CR50
Kombinationen von Penicillinen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DA32
Cefoperazon
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DA92
Cefquinom
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DB01
Cefalexin (intramammär)
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DB04
Cefazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DB90
Cefalonium
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DD12
Cefoperazone
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51DE90
Cefquinom
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51E
Sulfonamiden und Trimethoprim für intramammäre Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51FF90
Pirlimycin
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RC
Antibiotika Kombinationen für intramammäre Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RC01
Antibiotika Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RC22
Benzylpenicillin, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RC23
Procain Benzylpenicillin, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RC26
Cloxacillin, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RD01
Cefalexin, Kombinationen mit anderen antibakteriellen Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RF03
Lincomycin, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RG01
Neomycin, Kombinationen mit anderen Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51RV01
Antibiotika und Kortikosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
QJ51XX01
Rifaximin
WHO Anatomical Therapeutic Chemical classification
0‑L
QL01XE90
Protein-Kinase-Inhibitor
WHO Anatomical Therapeutic Chemical classification
0‑L
QL01XE91
Toceranib
WHO Anatomical Therapeutic Chemical classification
0‑L
QL03AB
Interferone
WHO Anatomical Therapeutic Chemical classification
0‑L
QL03AX
Immunstimulanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
QL04AD01
Ciclosporin
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AA01
Phenylbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AA90
Suxibuzon
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AC06
Meloxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AE03
Ketoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AE90
Vedaprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AE91
Carprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AE92
Tepoxalin
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AG02
Tolfenaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AG90
Flunixin
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AH90
Firocoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AH91
Robenacoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AH92
Mavacoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AH93
Cimicoxib
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AX12
Glykosaminoglykan Polysulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01AX90
Pentosan Polysulfat Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
QM01BA01
Phenylbutazon und Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
QM02AC99
Zubereitungen mit Salicylsäure-Derivaten, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QM03BX90
Guaifenesin
WHO Anatomical Therapeutic Chemical classification
0‑L
QM05BA05
Tiludronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
QM05BC01
Dibotermin alfa
WHO Anatomical Therapeutic Chemical classification
0‑L
QM09AX01
Hyaluronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01
Anaesthetika
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01AB06
Isofluran
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01AB08
Sevofluran
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01AC52
Methadon-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01AX03
Ketamin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01AX10
Propofol
WHO Anatomical Therapeutic Chemical classification
0‑L
QN01BA02
Procain
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02AB03
Fentanyl
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02AC52
Methadon-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02AE01
Buprenorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02AF
Morphinderivate
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02AF01
Butorphanol
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02BA01
Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02BA04
Natriumsalicylat
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02BB02
Metamizol Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02BB52
Metamizol Natrium, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
QN02BE01
Paracetamol
WHO Anatomical Therapeutic Chemical classification
0‑L
QN03AA02
Phenobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
QN03AX90
Imepitoin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN04BC02
Pergolid
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05AA04
Acepromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05BA01
Diazepam
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CB02
Barbiturate in Kombination mit anderen Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CM11
Bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CM18
Dexmedetomidine
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CM90
Detomidin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CM91
Medetomidin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN05CM92
Xylazin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN06AA04
Clomipramin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN06AB03
Fluoxetin
WHO Anatomical Therapeutic Chemical classification
0‑L
QN06BC01
Xanthin-Derivate, Coffein
WHO Anatomical Therapeutic Chemical classification
0‑L
QN51AA01
Pentobarbital
WHO Anatomical Therapeutic Chemical classification
0‑L
QNO5AD90
Azaperon
WHO Anatomical Therapeutic Chemical classification
0‑L
QP51AJ01
Toltrazuril
WHO Anatomical Therapeutic Chemical classification
0‑L
QP51AJ03
Diclazuril
WHO Anatomical Therapeutic Chemical classification
0‑L
QP51AX08
Halofuginon
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AA01
Praziquantel
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AA51
Praziquantel-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AA54
Epsiprantel, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC01
Triclabendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC02
Oxfendazole
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC05
Fenbantel
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC06
Netobimin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC08
Cambendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC09
Mebendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC11
Albendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC12
Flubendazole
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC13
Fenbendazol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AC55
Febantel-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52ACO1
Triclabendazole
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AE01
Levamisol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AE51
Levamisol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AF02
Pyrantel
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AG05
Rafoxanid
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AG09
Closantel
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AX09
Monepantel
WHO Anatomical Therapeutic Chemical classification
0‑L
QP52AX60
Emodepsid und Toltrazuril
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AC04
Permethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AC05
Flumethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AC11
Deltamethrin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AC54
Permethrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AC55
Flumethrin-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AD01
Amitraz
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AD51
Amitraz, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AE02
Propoxur
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AF01
Phoxime
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AF08
Guaifenesin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX04
Crotamiton
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX15
Fipronil
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX17
Imidacloprid
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX22
Thymol
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX23
Pyriproxifen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX25
Metaflumizone
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX26
Pyriprole
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX27
Indoxacarb
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53AX65
Fipronil-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53BC01
Lufenuron
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53BC51
Lufenuron, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53BD01
Methopren
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53BX02
Nitenpyram
WHO Anatomical Therapeutic Chemical classification
0‑L
QP53BX03
Spinosad
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AA01
Ivermectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AA03
Doramectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AA04
Epinomectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AA05
Selamectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AA51
Ivermectin-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AB02
Moxidectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AB51
Milbemycin Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QP54AB52
Moxidectin-Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
QR03CC13
Clenbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
QR03CC90
Clentbuterol Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
QR05CB01
Acetylcystein
WHO Anatomical Therapeutic Chemical classification
0‑L
QR05CB02
Bromhexin
WHO Anatomical Therapeutic Chemical classification
0‑L
QR05CB90
Dembrexin hydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
QS01AA13
Fusidinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
QS01AA90
Cloxacillin (ophtalmologische Präparate)
WHO Anatomical Therapeutic Chemical classification
0‑L
QS01XA18
Ciclosporin
WHO Anatomical Therapeutic Chemical classification
0‑L
QS02CA
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
QS02CA01
Prednisolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
QS02CA03
Hydrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
QS02CA91
Mometasone und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
QS02QA03
Ivermectin
WHO Anatomical Therapeutic Chemical classification
0‑L
QV03AB90
Atipamezole
WHO Anatomical Therapeutic Chemical classification
0‑L
QV03AN01
Oxygen
WHO Anatomical Therapeutic Chemical classification
0‑L
QV03AX
Nalfurafine
WHO Anatomical Therapeutic Chemical classification
0‑L
QV06DE
Kombinationen aus Aminosäuren, Elektroylten, Glucose und Vitaminen
WHO Anatomical Therapeutic Chemical classification
0‑L
R
Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
R01
Rhinologika
WHO Anatomical Therapeutic Chemical classification
0‑L
R01A
Dekongestiva und andere Rhinologika zur topischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA
Sympathomimetika, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA02
Cyclopentamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA03
Ephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA04
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA05
Oxymetazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA06
Tetryzolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA07
Xylometazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA08
Naphazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA09
Tramazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA10
Metizolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA11
Tuaminoheptan
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA12
Fenoxazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA13
Tymazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AA14
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB
Sympathomimetika, Kombinationen exkl. Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB01
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB02
Naphazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB03
Tetryzolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB05
Ephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB06
Xylometazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB07
Oxymetazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AB08
Tuaminoheptan
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC
Antiallergika, exkl. Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC01
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC02
Levocabastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC03
Azelastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC04
Antazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC05
Spagluminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC06
Thonzylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC07
Nedocromil
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC08
Olopatadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AC51
Cromoglicinsäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD
Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD01
Beclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD02
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD03
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD04
Flunisolid
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD05
Budesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD06
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD07
Tixocortol
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD08
Fluticason
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD09
Mometason
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD11
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD12
Fluticasonfuroat
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD52
Prednisolon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD53
Dexamethason, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD57
Tixocortol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD58
Fluticason, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AD60
Hydrocortison, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX
Andere Rhinologika
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX01
Calciumhexaminthiocyanat
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX02
Retinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX03
Ipratropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX05
Ritiometan
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX06
Mupirocin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX07
Hexamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX08
Framycetin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX10
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
R01AX30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01B
Nasale Dekongestiva zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA
Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA01
Phenylpropanolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA02
Pseudoephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA03
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA51
Phenylpropanolamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA52
Pseudoephedrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R01BA53
Phenylephrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R02
Hals- und Rachentherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
R02A
Hals- und Rachentherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA
Antiseptika
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA01
Ambazon
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA02
Dequalinium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA03
Dichlorbenzylalkohol
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA05
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA06
Cetylpyridinium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA09
Benzethonium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA10
Myristylbenzalkonium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA11
Chlorquinaldol
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA12
Hexylresorcinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA13
Acriflaviniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA14
Oxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA15
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA16
Benzalkonium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA17
Cetrimonium
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA18
Hexamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA19
Phenol
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AA20
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB01
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB02
Tyrothricin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB03
Fusafungin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB04
Bacitracin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AB30
Gramicidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AD
Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AD01
Benzocain
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AD02
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AD03
Cocain
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AD04
Dyclonin
WHO Anatomical Therapeutic Chemical classification
0‑L
R02AX01
Flurbiprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03
Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03A
Inhalative Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AA
Alpha- und Beta-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AA01
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AB
Nichtselektive Beta-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AB02
Isoprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AB03
Orciprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC
Selektive Beta-2-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC02
Salbutamol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC03
Terbutalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC04
Fenoterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC05
Rimiterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC06
Hexoprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC07
Isoetarin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC08
Pirbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC09
Tretoquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC10
Carbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC11
Tulobuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC12
Salmeterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC13
Formoterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC14
Clenbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC15
Reproterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC16
Procaterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AC17
Bitolterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AH
Kombinationen von Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK
Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK01
Epinephrin und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK02
Isoprenalin und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK03
Fenoterol und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK04
Salbutamol und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK05
Reproterol und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK06
Salmeterol und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03AK07
Formoterol und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03B
Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA
Glucocorticoide
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA01
Beclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA02
Budesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA03
Flunisolid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA04
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA05
Fluticason
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA06
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA07
Mometason
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BA08
Ciclesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BB
Anticholinergika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BB01
Ipratropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BB02
Oxitropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BB03
Stechapfel-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BB04
Tiotropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BC
Antiallergika, exkl. Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BC01
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BC03
Nedocromil
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BX
Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03BX01
Fenspirid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03C
Sympathomimetika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CA
Alpha- und Beta-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CA02
Ephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB
Nichtselektive Beta-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB01
Isoprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB02
Methoxyphenamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB03
Orciprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB51
Isoprenalin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CB53
Orciprenalin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC
Selektive Beta2-Adrenorezeptor-Agonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC02
Salbutamol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC03
Terbutalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC04
Fenoterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC05
Hexoprenalin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC06
Isoetarin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC07
Pirbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC08
Procaterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC09
Tretoquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC10
Carbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC11
Tulobuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC12
Bambuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC13
Clenbuterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC14
Reproterol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CC53
Terbutalin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03CK
Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03D
Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA
Xanthine
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA01
Diprophyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA02
Cholintheophyllinat
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA03
Proxyphyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA04
Theophyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA05
Aminophyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA06
Etamiphyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA07
Theobromin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA08
Bamifyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA09
Acefyllinpiperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA10
Bufyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA11
Doxofyllin
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA20
Kombinationen von Xanthinen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA51
Diprophyllin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA54
Theophyllin, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA55
Aminophyllin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA57
Theobromin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DA74
Theophyllin, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB
Xanthine und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB01
Diprophyllin und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB02
Cholintheophyllinat und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB03
Proxyphyllin und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB04
Theophyllin und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB05
Aminophyllin und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DB06
Etamiphyllin und Sympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DC
Leukotrienrezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DC01
Zafirlukast
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DC02
Pranlukast
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DC03
Montelukast
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DC04
Ibudilast
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX
Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX01
Amlexanox
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX02
Eprozinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX03
Fenspirid
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX05
Omalizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX06
Seratrodast
WHO Anatomical Therapeutic Chemical classification
0‑L
R03DX07
Roflumilast
WHO Anatomical Therapeutic Chemical classification
0‑L
R05
Husten- und Erkältungspräparate
WHO Anatomical Therapeutic Chemical classification
0‑L
R05C
Expektoranzien, exkl. Kombinationen mit Antitussiva
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA
Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA01
Tyloxapol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA02
Kaliumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA03
Guaifenesin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA04
Ipecacuanha
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA05
Eibischwurzel
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA06
Senega
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA07
Antimonpentasulfid
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA08
Kreosot
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA09
Guajacolsulfonat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA11
Levoverbenon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CA12
Hederae helicis folium
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB
Mukolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB01
Acetylcystein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB02
Bromhexin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB03
Carbocistein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB04
Eprazinon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB05
Mesna
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB06
Ambroxol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB07
Sobrerol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB08
Domiodol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB09
Letostein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB11
Stepronin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB12
Tiopronin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB13
Dornase alfa (Desoxyribonuclease)
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB14
Neltenexin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CB15
Erdostein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CP01
Thymiankraut
WHO Anatomical Therapeutic Chemical classification
0‑L
R05CP02
Efeublätter
WHO Anatomical Therapeutic Chemical classification
0‑L
R05D
Antitussiva, exkl. Kombinationen mit Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA
Opium-Alkaloide und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA01
Ethylmorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA03
Hydrocodon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA04
Codein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA05
Opium-Alkaloide mit Morphin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA06
Normethadon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA07
Noscapin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA08
Pholcodin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA09
Dextromethorphan
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA10
Thebacon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA11
Dimemorfan
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA12
Acetyldihydrocodein
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DA20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB
Andere Antitussiva
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB01
Benzonatat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB02
Benproperin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB03
Clobutinol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB04
Isoaminil
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB05
Pentoxyverin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB07
Oxolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB09
Oxeladin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB10
Clofedanol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB11
Pipazetat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB12
Bibenzoniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB13
Butamirat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB14
Fedrilat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB15
Zipeprol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB16
Dibunat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB17
Droxypropin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB18
Prenoxdiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB19
Dropropizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB21
Cloperastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB22
Meprotixol
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB23
Piperidion
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB24
Tipepidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB25
Morclofon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB26
Nepinalon
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB27
Levodropropizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R05DB28
Dimethoxanat
WHO Anatomical Therapeutic Chemical classification
0‑L
R05F
Antitussiva und Expektoranzien, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FA
Opium-Derivate und Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FA01
Opium-Derivate und Mukolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FA02
Opium-Derivate und Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FB
Andere Antitussiva und Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FB01
Antitussiva und Mukolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
R05FB02
Antitussiva und Expektoranzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R05X
Andere Kombinationspräparate gegen Erkältungskrankheiten
WHO Anatomical Therapeutic Chemical classification
0‑L
R06
Antihistaminika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R06A
Antihistaminika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA
Aminoalkylether
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA01
Bromazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA02
Diphenhydramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA04
Clemastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA06
Chlorphenoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA07
Diphenylpyralin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA08
Carbinoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA09
Doxylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA52
Diphenhydramin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA54
Clemastin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA56
Chlorphenoxamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AA57
Diphenylpyralin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB
Substituierte Alkylamine
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB01
Brompheniramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB02
Dexchlorpheniramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB03
Dimetinden
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB04
Chlorphenamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB05
Pheniramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB06
Dexbrompheniramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB07
Talastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB51
Brompheniramin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB52
Dexchlorpheniramin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB54
Chlorphenamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AB56
Dexbrompheniramin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC
Substituierte Ethylendiamine
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC01
Mepyramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC02
Histapyrrodin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC03
Chloropyramin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC04
Tripelennamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC05
Methapyrilen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC06
Thonzylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC52
Histapyrrodin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AC53
Chloropyramin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD
Phenothiazin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD01
Alimemazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD02
Promethazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD03
Thiethylperazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD04
Methdilazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD05
Hydroxyethylpromethazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD06
Thiazinam
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD07
Mequitazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD08
Oxomemazin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD09
Isothipendyl
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD52
Promethazin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AD55
Hydroxyethylpromethazin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE
Piperazin-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE01
Buclizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE03
Cyclizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE04
Chlorcyclizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE05
Meclozin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE06
Oxatomid
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE07
Cetirizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE09
Levocetirizin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE51
Buclizin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE53
Cyclizin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AE55
Meclozin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AK
Kombinationen von Antihistaminika
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX
Andere Antihistaminika zur systemischen Anwendung
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX01
Bamipin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX02
Cyproheptadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX03
Thenalidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX04
Phenindamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX05
Antazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX07
Triprolidin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX08
Pyrrobutamin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX09
Azatadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX11
Astemizol
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX12
Terfenadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX13
Loratadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX15
Mebhydrolin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX16
Deptropin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX17
Ketotifen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX18
Acrivastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX19
Azelastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX21
Tritoqualin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX22
Ebastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX23
Pimethixen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX24
Epinastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX25
Mizolastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX26
Fexofenadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX27
Desloratadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX28
Rupatadin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX29
Bilastin
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX53
Thenalidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R06AX58
Pyrrobutamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R07
Andere Mittel für den Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
R07A
Andere Mittel für den Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AA
Surfactant-Präparate
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AA01
Colfoscerilpalmitat
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AA02
Natürliche Phospholipide
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB
Atemstimulanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB01
Doxapram
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB02
Nikethamid
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB03
Pentetrazol
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB04
Etamivan
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB05
Bemegrid
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB06
Prethcamid
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB07
Almitrin
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB08
Dimeflin
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB09
Mepixanox
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB52
Nikethamid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AB53
Pentetrazol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AX
Andere Mittel für den Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
R07AX01
Stickoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
S
Sinnesorgane
WHO Anatomical Therapeutic Chemical classification
0‑L
S01
Ophthalmika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01A
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA01
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA02
Chlortetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA03
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA04
Oxytetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA05
Tyrothricin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA07
Framycetin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA09
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA10
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA11
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA12
Tobramycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA13
Fusidinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA14
Benzylpenicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA15
Dihydrostreptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA16
Rifamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA17
Erythromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA18
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA19
Ampicillin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA20
Antibiotika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA21
Amikacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA22
Micronomicin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA23
Netilmicin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA24
Kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA25
Azidamfenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA26
Azithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA27
Cefuroxim
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AA30
Kombinationen von Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB
Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB01
Sulfamethizol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB02
Sulfafurazol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB03
Sulfadicramid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB04
Sulfacetamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AB05
Sulfafenazol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD
Antivirale Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD01
Idoxuridin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD02
Trifluridin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD03
Aciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD05
Interferon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD06
Vidarabin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD07
Famciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD08
Fomivirsen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AD09
Ganciclovir
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AE01
Ofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX
Andere Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX01
Quecksilber-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX02
Silber-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX03
Zink-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX04
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX05
Bibrocathol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX06
Resorcin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX07
Natriumborat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX08
Hexamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX09
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX10
Natriumpropionat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX11
Ofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX12
Norfloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX13
Ciprofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX14
Dibrompropamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX15
Propamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX16
Picloxydin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX17
Lomefloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX18
Povidon-Iod
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX19
Levofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX21
Gatifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01AX22
Moxifloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01B
Antiphlogistika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA
Corticosteroide, rein
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA01
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA02
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA03
Cortison
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA04
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA05
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA06
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA07
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA08
Medryson
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA09
Clobetason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA10
Alclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA11
Desonid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA12
Formocortal
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA13
Rimexolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA14
Loteprednol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BA15
Fluocinolon acetonid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BB
Corticosteroide und Mydriatika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BB01
Hydrocortison und Mydriatika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BB02
Prednisolon und Mydriatika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BB03
Fluorometholon und Mydriatika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BB04
Betamethason und Mydriatika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC
Nichtsteroidale Antiphlogistika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC01
Indometacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC02
Oxyphenbutazon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC03
Diclofenac
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC04
Flurbiprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC05
Ketorolac
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC06
Piroxicam
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC07
Bendazac
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC08
Salicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC09
Pranoprofen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC10
Nepafenac
WHO Anatomical Therapeutic Chemical classification
0‑L
S01BC11
Bromfenac
WHO Anatomical Therapeutic Chemical classification
0‑L
S01C
Antiphlogistika und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA01
Dexamethason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA02
Prednisolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA03
Hydrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA04
Fluocortolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA05
Betamethason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA06
Fludrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA07
Fluorometholon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA08
Methylprednisolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA09
Chlorprednison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA10
Fluocinolonacetonid und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CA11
Clobetason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB
Corticosteroide/Antiinfektiva/Mydriatika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB01
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB02
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB03
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB04
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CB05
Fluorometholon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CC
Nichtsteroidale Antiphlogistika und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S01CC01
Diclofenac und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01E
Glaukommittel und Miotika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA
Sympathomimetika in der Glaukomtherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA01
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA02
Dipivefrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA03
Apraclonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA04
Clonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA05
Brimonidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EA51
Epinephrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB
Parasympathomimetika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB01
Pilocarpin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB02
Carbachol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB03
Ecothiopat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB04
Demecarium
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB05
Physostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB06
Neostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB07
Fluostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB08
Aceclidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB09
Acetylcholin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB10
Paraoxon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB51
Pilocarpin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EB58
Aceclidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC
Carboanhydrasehemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC01
Acetazolamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC02
Diclofenamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC03
Dorzolamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC04
Brinzolamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EC05
Methazolamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED
Beta-Adrenorezeptor-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED01
Timolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED02
Betaxolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED03
Levobunolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED04
Metipranolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED05
Carteolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED06
Befunolol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED51
Timolol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED52
Betaxolol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED54
Metipranolol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01ED55
Carteolol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE
Prostaglandin-Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE01
Latanoprost
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE02
Unoproston
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE03
Bimatoprost
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE04
Travoprost
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EE05
Tafluprost
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EX
Andere Glaukommittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EX01
Guanethidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01EX02
Dapiprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01F
Mydriatika und Zykloplegika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA
Anticholinergika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA01
Atropin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA02
Scopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA03
Methylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA04
Cyclopentolat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA05
Homatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA06
Tropicamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FA56
Tropicamid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FB
Sympathomimetika, exkl. Glaukommittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FB01
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FB02
Ephedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01FB03
Ibopamin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01G
Dekongestiva und Antiallergika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA
Sympathomimetika als Dekongestiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA01
Naphazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA02
Tetryzolin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA03
Xylometazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA04
Oxymetazolin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA05
Phenylephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA06
Oxedrin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA51
Naphazolin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA52
Tetryzolin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA53
Xylometazolin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA55
Phenylephrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GA56
Oxedrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX
Andere Antiallergika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX01
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX02
Levocabastin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX03
Spagluminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX04
Nedocromil
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX05
Lodoxamid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX06
Emedastin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX07
Azelastin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX08
Ketotifen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX09
Olopatadin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX10
Epinastin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01GX51
Cromoglicinsäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01H
Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA
Lokalanästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA01
Cocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA02
Oxybuprocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA03
Tetracain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA04
Proxymetacain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA05
Procain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA06
Cinchocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA07
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S01HA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01J
Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01JA
Farbstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
S01JA01
Fluorescein
WHO Anatomical Therapeutic Chemical classification
0‑L
S01JA02
Bengalrosa-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
S01JA51
Fluorescein, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01JX
Andere ophthalmologische Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01K
Chirurgische Hilfsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KA
Viskoelastische Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KA01
Hyaluronsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KA02
Hypromellose
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KA51
Hyaluronsäure, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KX
Andere chirurgische Hilfsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01KX01
Chymotrypsin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01L
Mittel gegen vaskuläre Augenerkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01LA
Antineovaskuläre Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S01LA01
Verteporfin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01LA02
Anecortav
WHO Anatomical Therapeutic Chemical classification
0‑L
S01LA03
Pegaptanib
WHO Anatomical Therapeutic Chemical classification
0‑L
S01LA04
Ranibizumab
WHO Anatomical Therapeutic Chemical classification
0‑L
S01X
Andere Ophthalmika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA
Andere Ophthalmika
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA01
Guajazulen
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA02
Retinol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA03
Natriumchlorid, hyperton
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA04
Kaliumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA05
Natriumedetat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA06
Ethylmorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA07
Alaun
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA08
Acetylcystein
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA09
Iodoheparinat
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA10
Inosin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA11
Nandrolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA12
Dexpanthenol
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA13
Alteplase
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA14
Heparin
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA15
Ascorbinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S01XA20
Künstliche Tränen und andere indifferente Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
S02
Otologika
WHO Anatomical Therapeutic Chemical classification
0‑L
S02A
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA01
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA02
Nitrofural
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA03
Borsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA04
Aluminiumacetattartrat
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA05
Clioquinol
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA06
Hydrogenperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA07
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA08
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA09
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA10
Essigsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA11
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA12
Rifamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA13
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA14
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA15
Ciprofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA16
Ofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S02AA30
Antiinfektiva, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S02B
Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
S02BA
Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
S02BA01
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
S02BA03
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S02BA06
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S02BA07
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S02C
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA01
Prednisolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA02
Flumetason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA03
Hydrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA04
Triamcinolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA05
Fluocinolonacetonid und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA06
Dexamethason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02CA07
Fludrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S02D
Andere Otologika
WHO Anatomical Therapeutic Chemical classification
0‑L
S02DA
Analgetika und Anästhetika
WHO Anatomical Therapeutic Chemical classification
0‑L
S02DA01
Lidocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S02DA02
Cocain
WHO Anatomical Therapeutic Chemical classification
0‑L
S02DA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S02DC
Indifferente Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S03
Ophthalmologische und otologische Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
S03A
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA
Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA01
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA02
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA03
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA04
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA05
Hexamidin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA06
Gentamicin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA07
Ciprofloxacin
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA08
Chloramphenicol
WHO Anatomical Therapeutic Chemical classification
0‑L
S03AA30
Antiinfektiva, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
S03B
Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
S03BA
Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
S03BA01
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S03BA02
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
S03BA03
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
S03C
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA
Corticosteroide und Antiinfektiva in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA01
Dexamethason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA02
Prednisolon und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA04
Hydrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA05
Fludrocortison und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03CA06
Betamethason und Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
S03D
Andere ophthalmologische und otologische Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V
Varia
WHO Anatomical Therapeutic Chemical classification
0‑L
V01
Allergene
WHO Anatomical Therapeutic Chemical classification
0‑L
V01A
Allergene
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA
Allergen-Extrakte
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA01
Federn
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA02
Gräserpollen
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA03
Hausstaub
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA04
Schimmel- und Hefepilze
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA05
Baumpollen
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA07
Insekten
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA08
Nahrungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA09
Textilien
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA10
Blüten
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA11
Tiere
WHO Anatomical Therapeutic Chemical classification
0‑L
V01AA20
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
V02
Immunosupressive agents
WHO Anatomical Therapeutic Chemical classification
0‑L
V02C
Immunosupressive agents
WHO Anatomical Therapeutic Chemical classification
0‑L
V02CA
Selective immunosuppressive agents
WHO Anatomical Therapeutic Chemical classification
0‑L
V03
Alle übrigen therapeutischen Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V03A
Alle übrigen therapeutischen Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AA
Drugs for treatment on chronic alcoholism
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB
Antidote
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB01
Ipecacuanha
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB02
Nalorphin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB03
Edetate
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB04
Pralidoxim
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB05
Prednisolon und Promethazin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB06
Thiosulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB08
Natriumnitrit
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB09
Dimercaprol
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB13
Obidoxim
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB14
Protamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB15
Naloxon
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB16
Ethanol
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB17
Methylthioniniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB18
Kaliumpermanganat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB19
Physostigmin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB20
Kupfersulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB21
Kaliumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB22
Amylnitrit
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB23
Acetylcystein
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB24
Digitalis-Antitoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB25
Flumazenil
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB26
Methionin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB27
4-Dimethylaminophenol
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB29
Cholinesterase
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB31
Eisen(III)hexacyanoferrat(II)
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB32
Glutathion
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB33
Hydroxocobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB34
Fomepizol
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AB35
Sugammadex
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AC
Eisen-Chelatbildner
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AC01
Deferoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AC02
Deferipron
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AC03
Deferasirox
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AE
Mittel zur Behandlung der Hyperkaliämie und Hyperphosphatämie
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AE01
Polystyrolsulfonat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AE02
Sevelamer
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AE03
Lanthan(III)-carbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AE04
Calciumacetat und Mangesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF
Entgiftungsmittel für die Behandlung mit Zytostatika
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF01
Mesna
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF02
Dexrazoxan
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF03
Calciumfolinat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF04
Calciumlevofolinat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF05
Amifostin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF06
Natriumfolinat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF07
Rasburicase
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF08
Palifermin
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AF09
Glucarpidase
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AG
Mittel zur Behandlung der Hyperkalzämie
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AG01
Natriumcellulosephosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AH
Mittel zur Behandlung der Hypoglykämie
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AH01
Diazoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AK
Gewebekleber
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AM
Mittel zur Embolisation
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN
Medizinische Gase
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN01
Sauerstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN02
Kohlendioxid
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN03
Helium
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN04
Stickstoff
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AN05
Medizinische Luft
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AX
Andere therapeutische Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AZ
Nerven dämpfende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V03AZ01
Ethanol
WHO Anatomical Therapeutic Chemical classification
0‑L
V04
Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V04AX
Other contrast media
WHO Anatomical Therapeutic Chemical classification
0‑L
V04B
Urin-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04C
Andere Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CA
Diabetes-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CA01
Tolbutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CA02
Glucose
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CB
Fettabsorptions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CB01
Vitamin-A-Konzentrate
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CC
Gallenfluss-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CC01
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CC02
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CC03
Sincalid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CC04
Ceruletid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CD
Hypophysenfunktions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CD01
Metyrapon
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CD03
Sermorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CD04
Corticoliberin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CD05
Somatorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CE
Leberfunktions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CE01
Galactose
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CE02
Bromsulfalein
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CF
Tuberkulose-Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CF01
Tuberkulin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG
Magensäuresekretions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG01
Kationenaustauscherharze
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG02
Betazol
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG03
Histaminphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG04
Pentagastrin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG05
Methylthioniniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CG30
Coffein und Natriumbenzoat
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH
Nierenfunktions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH01
Inulin und andere Polyfructosane
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH02
Indigokarmin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH03
Phenolsulfonphthalein
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH04
Alsactid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CH30
Aminohippursäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CJ
Schilddrüsenfunktions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CJ01
Thyrotropin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CJ02
Protirelin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CK
Pankreasfunktions-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CK01
Sekretin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CK02
Pankreozymin (Cholecystokinin)
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CK03
Bentiromid
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CL
Allergie-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CM
Fertilitäts-Tests
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CM01
Gonadorelin
WHO Anatomical Therapeutic Chemical classification
0‑L
V04CX
Andere Diagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V04D
Diagnostic radiopharmaceuticals
WHO Anatomical Therapeutic Chemical classification
0‑L
V06
Allgemeine Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
V06A
Diätetika zur Behandlung der Adipositas
WHO Anatomical Therapeutic Chemical classification
0‑L
V06AA
Niedrigkalorische Diäten
WHO Anatomical Therapeutic Chemical classification
0‑L
V06B
Proteinzusatznahrung
WHO Anatomical Therapeutic Chemical classification
0‑L
V06C
Säuglingsnahrung
WHO Anatomical Therapeutic Chemical classification
0‑L
V06CA
Diätetika ohne Phenylalanin
WHO Anatomical Therapeutic Chemical classification
0‑L
V06D
Andere Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DA
Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DB
Fette/Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DC
Kohlenhydrate
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DC01
Glucose
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DC02
Fructose
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DD
Aminosäuren, inkl. Kombination mit Polypeptiden
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DE
Aminosäuren/Kohlenhydrate/Mineralstoffe/Vitamine, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DF
Milchersatzstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
V06DX
Andere Diätetika-Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
V07
Alle übrigen nichttherapeutischen Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07A
Alle übrigen nichttherapeutischen Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AA
Pflaster
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AB
Lösungs- und Verdünnungsmittel, inkl. Spüllösungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AB01
Wasser
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AB02
Physiologische Kochsalzlösung
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AC
Bluttransfusionen, Hilfsstoffe
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AD
Blut-Tests, Hilfsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AN
Inkontinenz-Artikel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AR
Sensitivitäts-Tests, Plättchen und Tabletten
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AS
Stoma-Artikel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AT
Kosmetika
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AV
Technische Desinfektionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AX
Waschsubstanzen etc.
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AY
Andere nichttherapeutische Hilfsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V07AZ
Chemikalien und Reagenzien zur Analyse
WHO Anatomical Therapeutic Chemical classification
0‑L
V08
Kontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08A
Röntgenkontrastmittel, Iod-haltig
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA
Wasserlösliche nephrotrope hochosmolare Röntgenkontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA01
Amidotrizoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA02
Metrizoesäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA03
Iodamid
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA04
Iotalaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA05
Ioxitalaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA06
Ioglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA07
Acetrizoinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA08
Iocarminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA09
Methiodal
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AA10
Diodon
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB
Wasserlösliche nephrotrope niederosmolare Röntgenkontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB01
Metrizamid
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB02
Iohexol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB03
Ioxaglinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB04
Iopamidol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB05
Iopromid
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB06
Iotrolan
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB07
Ioversol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB08
Iopentol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB09
Iodixanol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB10
Iomeprol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB11
Iobitridol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AB12
Ioxilan
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC
Wasserlösliche hepatotrope Röntgenkontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC01
Iodoxaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC02
Iotroxinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC03
Ioglycaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC04
Adipiodon
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC05
Iobenzaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC06
Iopansäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC07
Iocetaminsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC08
Natriumiopodat
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC09
Tyropansäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AC10
Calciumiopodat
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AD
Wasserunlösliche Röntgenkontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AD01
Ethylester iodierter Fettsäuren
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AD02
Iopydol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AD03
Propyliodon
WHO Anatomical Therapeutic Chemical classification
0‑L
V08AD04
Iofendylat
WHO Anatomical Therapeutic Chemical classification
0‑L
V08B
Röntgenkontrastmittel, nicht Iod-haltig
WHO Anatomical Therapeutic Chemical classification
0‑L
V08BA
Bariumsulfat-haltige Röntgenkontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08BA01
Bariumsulfat mit Suspensionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08BA02
Bariumsulfat ohne Suspensionsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08C
Kontrastmittel für die Magnetresonanztomographie
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA
Paramagnetische Kontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA01
Gadopentetsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA02
Gadotersäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA03
Gadodiamid
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA04
Gadoteridol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA05
Mangafodipir
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA06
Gadoversetamid
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA07
Ammoniumeisen(III)citrat
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA08
Gadobensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA09
Gadobutrol
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA10
Gadoxetsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CA11
Gadofosveset
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CB
Superparamagnetische Kontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CB01
Ferumoxsil
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CB02
Ferristen
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CB03
Eisenoxid, Nanopartikel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CX
Andere Kontrastmittel für die Magnetresonanztomographie
WHO Anatomical Therapeutic Chemical classification
0‑L
V08CX01
Perflubron
WHO Anatomical Therapeutic Chemical classification
0‑L
V08D
Ultraschall-Kontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA
Ultraschall-Kontrastmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA01
Humanalbumin-Mikrosphären
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA02
Galactose-Mikropartikel
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA03
Perflenapent
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA04
Phospholipid-Mikrosphären
WHO Anatomical Therapeutic Chemical classification
0‑L
V08DA05
Schwefelhexafluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09
Radiodiagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V09A
Zentrales Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AA01
[99mTc]Technetium-Exametazim
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AA02
[99mTc]Technetiumbicisat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AB
[123I]Iod-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AB01
[123I]Iod-Iofetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AB02
[123I]Iod-Ioloprid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AB03
[123I]Iod-Ioflupan
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AX
Andere Radiodiagnostika für das zentrale Nervensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09AX01
[111In]Indiumpentetat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09B
Skelett
WHO Anatomical Therapeutic Chemical classification
0‑L
V09BA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09BA01
[99mTc]Technetiumoxidronat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09BA02
[99mTc]Technetiummedronat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09BA03
[99mTc]Technetiumpyrophosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09BA04
[99mTc]Technetiumbutedronat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09C
Nierensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA01
[99mTc]Technetiumpentetat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA02
[99mTc]Technetium-Succimer
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA03
[99mTc]Technetiummertiatid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA04
[99mTc]Technetiumglucoheptonat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CA05
[99mTc]Technetiumgluconat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CX
Andere Radiodiagnostika für das Nierensystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CX01
[123I]Natrium-Iodhippurat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CX02
[131I]Natrium-Iodhippurat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CX03
[125I]Natrium-Iodthalamat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09CX04
[51Cr]Chromedetat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09D
Leber- und Retikuloendothelialsystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA01
[99mTc]Technetium-Disofenin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA02
[99mTc]Technetium-Etifenin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA03
[99mTc]Technetium-Lidofenin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA04
[99mTc]Technetium-Mebrofenin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DA05
[99mTc]Technetium-Galtifenin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB
[99mTc]Technetium, Partikel und Kolloide
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB01
[99mTc]Technetium-Nanokolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB02
[99mTc]Technetium-Mikrokolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB03
[99mTc]Technetium-Millimikrosphären
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB04
[99mTc]Technetium-Zinn-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB05
[99mTc]Technetium-Schwefel-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB06
[99mTc]Technetium-Rheniumsulfid-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DB07
[99mTc]Technetiumphytat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DX
Andere Radiodiagnostika für das Leber- und Retikuloendothelialsystem
WHO Anatomical Therapeutic Chemical classification
0‑L
V09DX01
[75Se]Selenium-tauroselcholinat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09E
Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EA
[99mTc]Technetium, Inhalate
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EA01
[99mTc]Technetiumpentetat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EA02
[99mTc]Technetium, Technegas
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EA03
[99mTc]Technetium-Nanokolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EB
[99mTc]Technetium, Partikel zur Injektion
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EB01
[99mTc]Technetium-Macrosalb
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EB02
[99mTc]Technetium-Mikrosphären
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EX
Andere Radiodiagnostika für den Respirationstrakt
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EX01
[81mKr]Kryptongas
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EX02
[127Xe]Xenongas
WHO Anatomical Therapeutic Chemical classification
0‑L
V09EX03
[133Xe]Xenongas
WHO Anatomical Therapeutic Chemical classification
0‑L
V09F
Schilddrüse
WHO Anatomical Therapeutic Chemical classification
0‑L
V09FX
Verschiedene Radiodiagnostika für die Schilddrüse
WHO Anatomical Therapeutic Chemical classification
0‑L
V09FX01
[99mTc]Technetiumpertechnetat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09FX02
[123I]Natriumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09FX03
[131I]Natriumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09G
Kardiovaskuläres System
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA01
[99mTc]Technetiumsestamibi
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA02
[99mTc]Technetiumtetrofosmin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA03
[99mTc]Technetiumteboroxim
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA04
[99mTc]Technetium-Humanalbumin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA05
[99mTc]Technetiumfurifosmin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA06
[99mTc]Technetium-Zinn-markierte Zellen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GA07
[99mTc]Technetiumapcitid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GB
[125I]Iod-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GB01
[125I]Fibrinogen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GB02
[125I]Iod-Humanalbumin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GX
Andere Radiodiagnostika für das kardiovaskuläre System
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GX01
[201Tl]Thalliumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GX02
[111In]Indiumimciromab
WHO Anatomical Therapeutic Chemical classification
0‑L
V09GX03
[51Cr]Chromchromat-markierte Zellen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09H
ENtzündungs- und Infektionserkennung
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HA01
[99mTc]Technetium-Humanimmunglobulin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HA02
[99mTc]Technetium-Exametazim-markierte Zellen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HA03
[99mTc]Technetium-Antigranulozyten-Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HA04
[99mTc]Technetium-Sulesomab
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HB
[111In]Indium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HB01
[111In]Indiumoxinat-markierte Zellen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HB02
[111In]Indiumtropolonat-markierte Zellen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HX
Andere Radiodiagnostika zur Erkennung von Entzündungen und Infektionen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09HX01
[67Ga]Galliumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
V09I
Tumorerkennung
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA
[99mTc]Technetium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA01
[99mTc]Technetium-Anticarcinoembryoantigen-Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA02
[99mTc]Technetium-Antimelanom-Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA03
[99mTc]Technetiumsuccimer, pentavalent
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA04
[99mTc]Technetiumvotumumab
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA05
[99mTc]Technetiumdepreotid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IA06
[99mTc]Technetiumarcitumomab
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IB
[111In]Indium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IB01
[111In]Indiumpentetreotid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IB02
[111In]Indium-Satumomab-pendetid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IB03
[111In]Indium-Antiovariumkarzinom-Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IB04
[111In]Indium-Capromab-Pendetid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX
Andere Radiodiagnostika zur Tumorerkennung
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX01
[123I]Iobenguan
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX02
[131I]Iobenguan
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX03
[125I]Iod-CC49-Monoklonaler Antikörper
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX04
[18F]Fludeoxyglucose
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX05
[18F]Fluorodopa
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX06
[18F]Natriumfluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V09IX07
[18F]Fluormethylcholin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09X
Andere Radiodiagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XA
[131I]Iod-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XA01
[131I]Iodnorcholesterol
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XA02
[131I]Iodcholesterol
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XA03
[131I]Iod- Humanalbumin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XX
Verschiedene Radiodiagnostika
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XX01
[57Co]Cobaltcyanocobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XX02
[58Co]Cobaltcyanocobalamin
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XX03
[75Se]Selennorcholesterol
WHO Anatomical Therapeutic Chemical classification
0‑L
V09XX04
[59Fe]Eisen(III)-citrat
WHO Anatomical Therapeutic Chemical classification
0‑L
V10
Radiotherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
V10A
Entzündungshemmende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AA
[90Y]Yttrium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AA01
[90Y]Yttriumcitrat-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AA02
[90Y]Yttrium-Eisen(III)hydroxid-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AA03
[90Y]Yttriumsilicat-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX
Andere entzündungshemmende Radiotherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX01
[32P]Chrom(III)phosphat-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX02
[153Sm]Samariumhydroxyapatit-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX03
[165Dy]Dysprosium-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX04
[169Er]Erbiumcitrat-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX05
[186Re]Rheniumsulfid-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10AX06
[198Au]Gold-Kolloid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10B
Schmerzlinderung (Knochenmetastasen)
WHO Anatomical Therapeutic Chemical classification
0‑L
V10BX
Verschiedene Radiopharmaka zur Schmerzlinderung
WHO Anatomical Therapeutic Chemical classification
0‑L
V10BX01
[89Sr]Strontiumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10BX02
[153Sm]Samariumlexidronam
WHO Anatomical Therapeutic Chemical classification
0‑L
V10BX03
[186Re]Rheniumetidronat
WHO Anatomical Therapeutic Chemical classification
0‑L
V10X
Andere Radiotherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XA
[131I]Iod-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XA01
[131I]Natriumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XA02
[131I]Iobenguan
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XA53
Tositumomab/[131I]Iod-Tositumomab
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XX
Verschiedene Radiotherapeutika
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XX01
[32P]Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
V10XX02
[90Y] Ibritumomab tiuxetan
WHO Anatomical Therapeutic Chemical classification
0‑L
V20
Wundverbände
WHO Anatomical Therapeutic Chemical classification

 
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.
download XML JSON CSV SQL SVS